Anti-SARS-CoV-2 vaccine-induced myocarditis – real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology

array:24 ["pii" => "S0870255123000173" "issn" => "08702551" "doi" => "10.1016/j.repc.2023.01.003" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2092" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Rev Port Cardiol. 2023;42:161-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S087025512200525X" "issn" => "08702551" "doi" => "10.1016/j.repc.2022.12.007" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2081" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Rev Port Cardiol. 2023;42:169.e1-169.e4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Case report" "titulo" => "Inflammatory myofibroblastic tumor: A rare entity with a complex diagnosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "169.e1" "paginaFinal" => "169.e4" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 400 "Ancho" => 1005 "Tamanyo" => 66910 ] ] "descripcion" => array:1 [ "en" => "(A) Coronal view of thoraco-abdominal computed tomography scan before the first surgery. A left atrial tumor is observed extending into the right inferior pulmonary vein outlet; (B) mass resected during the first surgery, elastic in consistency with protuberant characteristics and mother-of-pearl surface color. Part of the interatrial septum can be observed at its base." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos Domínguez-Massa, Lucía Doñate-Bertolín, Óscar R. Blanco-Herrera, Tomás Heredia-Cambra, Manuel Pérez-Guillén, Vicent Martínez-Cózar, Empar Mayordomo-Aranda, Fernando Hornero-Sos" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Carlos" "apellidos" => "Domínguez-Massa" ] 1 => array:2 [ "nombre" => "Lucía" "apellidos" => "Doñate-Bertolín" ] 2 => array:2 [ "nombre" => "Óscar R." "apellidos" => "Blanco-Herrera" ] 3 => array:2 [ "nombre" => "Tomás" "apellidos" => "Heredia-Cambra" ] 4 => array:2 [ "nombre" => "Manuel" "apellidos" => "Pérez-Guillén" ] 5 => array:2 [ "nombre" => "Vicent" "apellidos" => "Martínez-Cózar" ] 6 => array:2 [ "nombre" => "Empar" "apellidos" => "Mayordomo-Aranda" ] 7 => array:2 [ "nombre" => "Fernando" "apellidos" => "Hornero-Sos" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S087025512200525X?idApp=UINPBA00004E" "url" => "/08702551/0000004200000002/v1_202302081302/S087025512200525X/v1_202302081302/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0870255122005248" "issn" => "08702551" "doi" => "10.1016/j.repc.2022.12.006" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2080" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2023;42:157-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial comment" "titulo" => "Three-dimensional transesophageal echocardiography – An added value tool for the assessment of aortic plaques in ischemic stroke" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "157" "paginaFinal" => "159" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ecocardiografia transesofágica 3D – uma ferramenta de valor acrescentado para a avaliação de placas aórticas no acidente vascular cerebral isquémico" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Ribeiro" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José" "apellidos" => "Ribeiro" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255122005248?idApp=UINPBA00004E" "url" => "/08702551/0000004200000002/v1_202302081302/S0870255122005248/v1_202302081302/en/main.assets" ] "en" => array:17 [ "idiomaDefecto" => true "cabecera" => "State of the Art" "titulo" => "Anti-SARS-CoV-2 vaccine-induced myocarditis – real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "161" "paginaFinal" => "167" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José Pedro Sousa, David Roque, Cláudio Guerreiro, Rogério Teixeira" "autores" => array:5 [ 0 => array:4 [ "nombre" => "José Pedro" "apellidos" => "Sousa" "email" => array:1 [ 0 => "zpedro_14@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "David" "apellidos" => "Roque" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Cláudio" "apellidos" => "Guerreiro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Rogério" "apellidos" => "Teixeira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 4 => array:1 [ "colaborador" => "on behalf of the Studies Committee of the Portuguese Society of Cardiology" ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Hospital Prof. Doutor Fernando Fonseca, EPE, Amadora, Portugal" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Miocardite induzida pela vacinação anti-SARS-CoV-2 – Real, mas, em geral, rara e ligeira: tomada de posição por parte da comissão de estudos da Sociedade Portuguesa de Cardiologia" ] ] "textoCompleto" => "IntroductionThe evidence currently pointing to an association between vaccination against COVID-19 (coronavirus disease 2019) and the onset of inflammatory heart disease – principally acute myocarditis, but also acute pericarditis – is, in our view, unequivocal. Many case series from different continents have been published in some of the most important peer-reviewed journals, including the New England Journal of Medicine (NEJM),<a class="elsevierStyleCrossRefs" href="#bib0335">1–3</a> the Journal of the American Medical Association (JAMA),<a class="elsevierStyleCrossRefs" href="#bib0350">4,5</a> including JAMA Cardiology,<a class="elsevierStyleCrossRefs" href="#bib0360">6–8</a>JAMA Internal Medicine<a class="elsevierStyleCrossRef" href="#bib0375">9</a> and JAMA Network Open,<a class="elsevierStyleCrossRef" href="#bib0380">10</a> the British Medical Journal (BMJ),<a class="elsevierStyleCrossRef" href="#bib0385">11</a>Nature Medicine,<a class="elsevierStyleCrossRef" href="#bib0390">12</a>Circulation,<a class="elsevierStyleCrossRefs" href="#bib0395">13–15</a>Vaccine,<a class="elsevierStyleCrossRefs" href="#bib0410">16,17</a>Pediatrics<a class="elsevierStyleCrossRef" href="#bib0420">18</a> and the Journal of Pediatrics.<a class="elsevierStyleCrossRefs" href="#bib0425">19,20</a> Additionally, many others have been pre-published.<a class="elsevierStyleCrossRefs" href="#bib0435">21–23</a> Furthermore, since as early as July last year, the Advisory Committee on Immunization Practices (ACIP) of the US Centers for Disease Control and Prevention (CDC) had deemed the existence of a causal relationship between anti-SARS-CoV-2 vaccination and the recurring reports of acute myocarditis and pericarditis syndromes as “probable”.<a class="elsevierStyleCrossRefs" href="#bib0450">24–26</a> For this appraisal, it made use of the Vaccine Adverse Event Reporting System (VAERS) database and, in particular, the Vaccine Safety Datalink (VSD)<a class="elsevierStyleCrossRef" href="#bib0465">27</a> system. Although it has traditionally been associated with low specificity, generating hypotheses (safety signs) rather than confirming them,<a class="elsevierStyleCrossRef" href="#bib0465">27</a> the concern is now that this database may be underestimating the actual cases of acute myocarditis induced by anti-COVID-19 vaccines.<a class="elsevierStyleCrossRef" href="#bib0435">21</a>In addition to the quantity and diversity of information sources and publications, this link between anti-SARS-CoV-2 vaccines and incident episodes of acute myocarditis is also – or even primarily – reinforced by the notable reproducibility of its presentation pattern: (i) rare and stochastic appearance<a class="elsevierStyleCrossRefs" href="#bib0335">1,2,6,12</a>; (ii) higher risk in adolescents and young adults, especially if male<a class="elsevierStyleCrossRefs" href="#bib0340">2,3,25,28</a>; (iii) tendency to occur after the second vaccine dose, especially with messenger RNA (mRNA) technology – and, among this subgroup, particularly with the mRNA-1273 vaccine (Moderna), rather than the BNT162b2 vaccine (Pfizer-BioNTech)<a class="elsevierStyleCrossRefs" href="#bib0380">10–12,22</a>; (iv) relatively mild clinical manifestations, usually dominated by chest pain and with neither heart failure nor electrical instability<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a>; and (v) rapid recovery in both clinical and laboratory terms.<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a>Moreover, it is not unprecedented for episodes of acute myopericarditis to be causally connected with vaccine-triggered immune responses. In fact, increases in the incidence of such events have been reported in the context of vaccination against hepatitis B, influenza, and historically – and with higher likelihood – smallpox.<a class="elsevierStyleCrossRef" href="#bib0475">29</a> Interestingly, in these studies, a predisposition for the young male population to be affected was also noted. At all events, this emulates the general epidemiological pattern associated with idiopathic myopericarditis, and not just that of iatrogenic etiology.<a class="elsevierStyleCrossRef" href="#bib0460">26</a>Probability of occurrenceConsidering the general population, it can be assumed that the risk of post-COVID-19 vaccination acute myocarditis (in particular) and/or pericarditis is very low. For instance, in the NEJM in September 2021, Barda and co-investigators,<a class="elsevierStyleCrossRef" href="#bib0335">1</a> using data from the largest healthcare provider organization in Israel – including about 1.7 million people (half unvaccinated and half who received the Pfizer-BioNTech BNT162b2 vaccine) – reported 2.7 cases of myocarditis per 100000 vaccinated individuals. Additionally, in December 2021, also reporting on an Israeli population sample inoculated with BNT162b2, Mevorach et al.<a class="elsevierStyleCrossRef" href="#bib0340">2</a> noted the occurrence of only 136 cases of acute myocarditis among more than five million vaccinated individuals. Furthermore, in the same month, Nature Medicine published a paper by Patone and co-workers,<a class="elsevierStyleCrossRef" href="#bib0390">12</a> who recorded an incidence of acute myocarditis no greater than one case per 100000 first or second shots of the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) mRNA vaccines among an English population aged 16 years or older.However, as stated above, the burden of this inflammatory complication of anti-SARS-CoV-2 vaccination falls asymmetrically on male adolescents and young adults, especially in the setting of the second dose of an mRNA vaccine, and particularly of Moderna's mRNA-1273 vaccine.<a class="elsevierStyleCrossRefs" href="#bib0340">2,3,25,28</a> An analysis of this group's specific risk therefore seems appropriate. Firstly, the importance of young age is well documented. For instance, a third study from Israel, also published in the NEJM,<a class="elsevierStyleCrossRef" href="#bib0345">3</a> analyzed about 2.5 million individuals aged 16 years or older who were inoculated at least once with the BNT162b2 vaccine. In this case, rather than the general acute myocarditis incidence of 2.1 cases per 100000 people, a figure of 10.7/100000 would instead be obtained if only individuals aged between 16 and 29 years were considered. In addition, the previously cited paper by Mevorach et al.<a class="elsevierStyleCrossRef" href="#bib0340">2</a> lends support to the role of male gender as a major predictor of post-vaccine myocarditis, since, after a second dose of the BNT162b2 vaccine, its likelihood was estimated at about 1/26000 in men (maximum of 1/6637 among those aged between 16 and 19 years), while reaching only 1/218000 in women (1/99853 among those aged between 16 and 19 years). Moreover, the importance of receiving the second rather than the first dose of a COVID-19 mRNA – rather than viral vector – vaccine, in terms of the risk of acute myocarditis, is demonstrated by the study by Patone and co-workers cited above.<a class="elsevierStyleCrossRef" href="#bib0390">12</a> In this analysis, among a population under the age of 40 and receiving a second shot, its likelihood was estimated at less than 0.5/100000, about 1/100000 and 1.5/100000 after the administration of the viral vector ChAdOx1 (AstraZeneca-Oxford), BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines, respectively. Moreover, in a recent publication in the BMJ<a class="elsevierStyleCrossRef" href="#bib0385">11</a> encompassing about five million Danes aged 12 years or older, the importance of the commercial formulation of the mRNA vaccine became apparent: the rate of acute myocarditis and/or pericarditis cases diagnosed after immunization with the mRNA-1273 vaccine was 6.3 per 100000 men and 2 per 100000 women, whereas the risk attributable to the BNT162b2 vaccine was markedly lower, especially in males: 1.5/100000 in men and 1.3/100000 in women.Pathophysiological basesSince the epidemiological association between anti-SARS-CoV-2 mRNA vaccines and acute myocarditis and pericarditis has not only been confirmed but also consistently quantified, it seems natural for research to be carried out directed at the pathophysiology underlying the myopericardial inflammation potentially generated by these vaccines. At the present time, its mechanistic basis remains unknown.<a class="elsevierStyleCrossRef" href="#bib0460">26</a> Nevertheless, several hypotheses have been raised.The most frequently discussed potential pathophysiological process<a class="elsevierStyleCrossRefs" href="#bib0460">26,30,31</a> is a possible molecular mimicry between the spike protein of SARS-CoV-2 – the biological target of mRNA vaccines – and a particular myocardial structural protein, possibly alpha-myosin. It has been postulated that this may lead to cross-reactivity and thence the synthesis of autoantibodies, which may be harmful to tissue containing the relevant antigens – in this case, the myocardium.<a class="elsevierStyleCrossRefs" href="#bib0460">26,30,31</a> This rationale – similar to that previously conceived for the development of rheumatic heart disease after Lancefield group A streptococcus infection<a class="elsevierStyleCrossRef" href="#bib0490">32</a> – currently suffers from a lack of laboratory documentation of the theorized cardiac autoantibodies.Another hypothesis<a class="elsevierStyleCrossRef" href="#bib0485">31</a> – not incompatible with the first and, by contrast, already backed by basic research, even though carried out in other settings<a class="elsevierStyleCrossRefs" href="#bib0495">33–36</a> – is the possibility of sex hormones exerting differential and even contrasting effects. In this case, the tendency of adolescents and young men to develop post-vaccine myocarditis suggests the possibility of a harmful effect of testosterone, which has previously been repeatedly implicated<a class="elsevierStyleCrossRefs" href="#bib0495">33,34</a> in proinflammatory and poorly adaptive responses, in terms of both injury prevention and repair, at the cardiomyocyte level. By contrast, estrogens have been shown to exert anti-inflammatory effects and to negatively regulate cellular immune responses, mainly in the context of fundamental research undertaken in murine models.<a class="elsevierStyleCrossRefs" href="#bib0505">35,36</a> More broadly, this theory of hormonal modulation of immunoinflammatory processes could explain why male gender represents a prominent risk factor for many other entities in the spectrum of myocarditis<a class="elsevierStyleCrossRef" href="#bib0460">26</a> – and, most importantly, for the most common idiopathic or viral types, which could include that induced by SARS-CoV-2 itself.<a class="elsevierStyleCrossRef" href="#bib0515">37</a> On the other hand, the proponents of this hypothesis<a class="elsevierStyleCrossRefs" href="#bib0495">33,34</a> also recognize its main limitation: its inability to explain the apparent cardiac specificity of this biological response.Finally, and given not only that post-vaccine myocarditis seems to affect a very limited subset of patients (even when all the published studies are grouped and the possibility of reporting underestimation is acknowledged<a class="elsevierStyleCrossRef" href="#bib0435">21</a>), who, additionally, tend to recover quickly,<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> but also that a specific animal model of the condition is currently unavailable, our real ignorance of its pathophysiological basis is likely to persist.<a class="elsevierStyleCrossRef" href="#bib0485">31</a>Diagnosis, treatment and prognosisAs mentioned above, the clinical presentation and course of anti-SARS-CoV-2 vaccination-associated myocarditis reveal surprising homogeneity, particularly in its mild intensity and rapid resolution,<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> with or without treatment, which is fundamentally supportive.<a class="elsevierStyleCrossRef" href="#bib0520">38</a> The two largest series published in academic journals to date featuring detailed clinical descriptions are Witberg et al.<a class="elsevierStyleCrossRef" href="#bib0345">3</a> in the NEJM, with 54 patients, and Truong et al.<a class="elsevierStyleCrossRef" href="#bib0405">15</a> in Circulation, with 139.With regard to clinical presentation, it is important to highlight that chest pain is by far the most common manifestation, affecting as many as 99% of the patients in the study by Truong et al.,<a class="elsevierStyleCrossRef" href="#bib0405">15</a> and at least 81% in Witberg et al.<a class="elsevierStyleCrossRef" href="#bib0345">3</a> The second most common symptom is fever, followed by dyspnea. These were present in 9–31% and 6–27% of these population samples, respectively.<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> It therefore comes as a surprise to us that the CDC-endorsed<a class="elsevierStyleCrossRef" href="#bib0450">24</a> definition of a confirmed case of post-vaccine myocarditis assigns equal value to all cardiac manifestations – dyspnea, palpitations and syncope as well as chest pain – and does not even include fever.Concerning complementary assessment, the electrocardiogram (ECG) is, in this setting, most likely to be altered. Between 70% (in the study by Truong and colleagues<a class="elsevierStyleCrossRef" href="#bib0405">15</a>) and 79% (in Witberg et al.<a class="elsevierStyleCrossRef" href="#bib0345">3</a>) of these exams show significant abnormalities, particularly of the ST segment (especially elevation, reflecting the concomitant presence of acute pericarditis) and of the T wave, which are present in 68–70% of cases. This naturally bolsters the role of the ECG as a screening tool. In turn, it should be noted that the previously mentioned definition<a class="elsevierStyleCrossRef" href="#bib0450">24</a> of confirmed post-vaccine myocarditis, as proposed by the CDC, in the absence of histopathological confirmation, requires both elevated troponin and cardiac magnetic resonance imaging (CMRI) findings consistent with myocarditis. The ubiquity of these criteria in the above-mentioned case series<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> is therefore to be expected. Even so, elevations of blood biomarkers of myocardial injury are, as a rule, modest<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> and global left ventricular systolic function is generally preserved, with mean left ventricular ejection fraction (LVEF) as estimated by CMRI of 60% in the study by Truong and colleagues.<a class="elsevierStyleCrossRef" href="#bib0405">15</a> In this analysis, the key anomalies detected by this imaging technique were the presence of late gadolinium enhancement, in 76% of patients, and of myocardial edema, in 56%. Importantly, the Lake Louise criteria for myocarditis were met in only 51%. Truong et al.<a class="elsevierStyleCrossRef" href="#bib0405">15</a> also reported that, on transthoracic echocardiography, only 3% of the sample presented moderate to severe left ventricular systolic dysfunction and only one patient exhibited pericardial effusion, which was small.Since in this specific context (but also in many others falling within the spectrum of acute myocarditis and chronic inflammatory cardiomyopathy) there have been no randomized controlled clinical trials, nor are there likely to be, assessing patient-centered clinical outcomes,<a class="elsevierStyleCrossRef" href="#bib0525">39</a> specific treatment cannot be recommended.<a class="elsevierStyleCrossRefs" href="#bib0460">26,38</a> However, as a rule, conventional pharmacotherapy generally initiated in heart failure settings – in particular, angiotensin-converting enzyme inhibitors and beta-blockers – should be considered,<a class="elsevierStyleCrossRefs" href="#bib0460">26,38</a> and escalation to sacubitril-valsartan, mineralocorticoid receptor antagonists and/or sodium-glucose type 2 co-transporter inhibitors may be performed in cases in which moderate-to-severe left ventricular systolic dysfunction is detected.<a class="elsevierStyleCrossRef" href="#bib0530">40</a> Of course, the clinical indication for all these agents should be reassessed during follow-up consultation.<a class="elsevierStyleCrossRefs" href="#bib0460">26,38</a> There is no contraindication to the use of non-steroidal anti-inflammatory drugs<a class="elsevierStyleCrossRefs" href="#bib0460">26,38</a> if LVEF is not reduced. By contrast, immunomodulatory agents – with the possible exception of colchicine, which is indicated in most cases of associated acute pericarditis<a class="elsevierStyleCrossRefs" href="#bib0520">38,41</a> – should be applied cautiously. In particular, intravenous corticosteroids and immunoglobulins should be considered only in the most severe cases, and always on an individual basis.<a class="elsevierStyleCrossRefs" href="#bib0520">38,42</a> Chest pain can also be addressed with, for example, paracetamol and opioid agents, in addition to the aforementioned non-steroidal anti-inflammatory drugs.<a class="elsevierStyleCrossRef" href="#bib0520">38</a>A diagnosis of acute myocarditis mandates hospitalization in the majority of cases, even if its clinical course is expected to be brief and uncomplicated. In this context, Truong et al.<a class="elsevierStyleCrossRef" href="#bib0405">15</a> report a median of only two days of hospitalization. Therefore, it is not surprising that only two patients in their study<a class="elsevierStyleCrossRef" href="#bib0405">15</a> and one in that of Witberg and colleagues<a class="elsevierStyleCrossRef" href="#bib0345">3</a> eventually required pharmacological inotropic or vasopressor support. More importantly, only one patient, reported in the study by Witberg et al.,<a class="elsevierStyleCrossRef" href="#bib0345">3</a> needed to be rescued with mechanical circulatory support, and none actually died.<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> However, it should be noted that other investigators<a class="elsevierStyleCrossRef" href="#bib0540">42</a> have reported post-COVID-19 vaccine cases of fulminant myocarditis and significant ventricular dysrhythmia. Reassuringly, however, death attributable to these remains an exception.<a class="elsevierStyleCrossRef" href="#bib0545">43</a>Comparison with the risk of severe SARS-CoV-2 infectionAlthough, as described above, the risk of acute myocarditis in the context of anti-SARS-CoV-2 vaccination appears to be real, it seems appropriate to compare it with that of severe COVID-19 disease.<a class="elsevierStyleCrossRefs" href="#bib0335">1,24–26</a> This stems from the fact that the majority of the world's population is likely, sooner or later, to come into contact with SARS-CoV-2.<a class="elsevierStyleCrossRefs" href="#bib0550">44,45</a> Thus, the personal option not to be vaccinated should not, in this context, be interpreted as a risk-free strategy, but rather as the personal selection of a different risk,<a class="elsevierStyleCrossRef" href="#bib0555">45</a> perhaps an even more serious one.From early on, the CDC sought to present estimates of the risk-benefit ratio of anti-COVID-19 vaccination.<a class="elsevierStyleCrossRefs" href="#bib0450">24–26</a> While it is indisputable that older age groups – in which the risk of post-vaccine myocarditis is even lower<a class="elsevierStyleCrossRefs" href="#bib0340">2,3,25,28</a> – have significantly more severe infection-related complications,<a class="elsevierStyleCrossRefs" href="#bib0560">46,47</a> the CDC's analysis could have raised doubts in the subgroup that has shown greater predilection toward development of myocarditis, that is, young males,<a class="elsevierStyleCrossRefs" href="#bib0340">2,3,25,28</a> who also happen to be more likely to be spared from severe COVID-19 disease.<a class="elsevierStyleCrossRefs" href="#bib0560">46,47</a> However, such uncertainty may be resolved through a simple case-by-case analysis of the already published data.<a class="elsevierStyleCrossRefs" href="#bib0450">24–26</a> This shows that for every million second doses of anti-SARS-CoV-2 mRNA vaccines administered to this fringe population, 12000 cases of COVID-19 are expected to be prevented, along with 530 hospitalizations, 127 intensive care unit admissions and three deaths, while only 45–56 cases of acute myocarditis are anticipated to ensue. The study by Barda et al. referred to above<a class="elsevierStyleCrossRef" href="#bib0335">1</a> also sought to help resolve this dispute, noting that use of the Pfizer-BioNTech BNT162b2 vaccine significantly reduces the risk of numerous other conditions, including acute myocardial infarction, intracranial hemorrhage, pulmonary embolism, deep vein thrombosis, clinically significant dysrhythmia and acute kidney injury, in comparisons between vaccinated and unvaccinated individuals and between infected and uninfected persons. Additionally, other important viral complications, such as systemic inflammatory syndrome in both infants and adults,<a class="elsevierStyleCrossRef" href="#bib0570">48</a> and post-acute sequelae of the infection in the form of so-called long COVID<a class="elsevierStyleCrossRef" href="#bib0575">49</a> also appear to be effectively prevented by vaccination.On the other hand, a favorable risk-benefit balance of anti-SARS-CoV-2 mRNA vaccination can be immediately inferred just by looking at the condition of acute myocarditis per se. Barda et al.<a class="elsevierStyleCrossRef" href="#bib0335">1</a> have shown that the probability of this diagnosis increases by a factor of 3.2 after vaccine administration and by 18.3 after COVID-19 infection itself. Additionally, in the study by Patone et al.,<a class="elsevierStyleCrossRef" href="#bib0390">12</a> with the aforementioned estimate of <1 post-vaccine myocarditis case per 100000 vaccinated individuals, a 4/100000 chance of acute myocarditis was ascribed to the unvaccinated population sample. Furthermore, the clinical consequences of post-vaccine and post-infection myocarditis also appear to differ: while the former, as previously stated,<a class="elsevierStyleCrossRefs" href="#bib0345">3,15</a> tends to follow a rapid, mild and uncomplicated course, the latter has been associated – in some<a class="elsevierStyleCrossRefs" href="#bib0580">50,51</a> but not all<a class="elsevierStyleCrossRefs" href="#bib0590">52,53</a> reviews on this matter – with adverse outcomes of various kinds, including death.Conclusion and future prospectsBased on the currently available scientific evidence, the benefits conferred by anti-SARS-CoV-2 vaccination far outweigh the risks attributed to it,<a class="elsevierStyleCrossRefs" href="#bib0450">24–26</a> particularly with regard to acute myocarditis. Thus, as far as the initially recommended scheme for mRNA vaccine rollout – two doses in all individuals aged 12 years or older<a class="elsevierStyleCrossRefs" href="#bib0600">54–57</a> – is concerned, the Studies Committee of the Portuguese Society of Cardiology recommends its routine use. Although this conflicts with some health policies adopted in northern European countries,<a class="elsevierStyleCrossRef" href="#bib0620">58</a> it also supports the use of the mRNA-1273 (Moderna) formulation in this setting. In this way, the Committee hopes to contribute decisively to persuading the fringe populations that currently refuse to be vaccinated. Fortunately, regarding the mRNA vaccine rollout in children aged 5–11 years<a class="elsevierStyleCrossRef" href="#bib0625">59</a> and as a three-dose strategy,<a class="elsevierStyleCrossRef" href="#bib0630">60</a> no significant warning signs have thus far been detected. In fact, notwithstanding the rather scant scientific evidence currently at our disposal, the risk of acute myocarditis appears to be even lower in these scenarios. Regarding the former, it seems less than that ascribed to young adults, even in males, thus supporting the previously mentioned hypothesis of hormonal modulation of immune phenomena,<a class="elsevierStyleCrossRef" href="#bib0485">31</a> while as for the latter, the third dose also appears to pose a lesser threat in this instance, at least compared to the second dose. Of course, these observations should not restrict upcoming research in this area. As a matter of fact, the Committee would push for future studies focusing on the evaluation of even lower vaccine doses and longer inter-vaccine intervals in the population with greater predilection toward development of post-vaccine acute myocarditis. On the other hand, by its conditional endorsement of these childhood and booster vaccination strategies, the Committee does not aim to deny the paramount importance of worldwide anti-SARS-CoV-2 vaccination efforts. In fact, it goes as far as to consider that developing countries should even be favored,<a class="elsevierStyleCrossRef" href="#bib0635">61</a> as it believes this constitutes the most effective means for stemming the emergence of new variants.<a class="elsevierStyleCrossRef" href="#bib0640">62</a> It is crucial to bear in mind that these – of which Omicron naturally currently has a prominent place<a class="elsevierStyleCrossRefs" href="#bib0640">62,63</a> – may even demonstrate the ability to impact on the favorable risk-benefit ratio currently attributed to vaccination, at least with regard to its effectiveness.Finally, a challenging situation that some Portuguese cardiologists will have to face over the course of their clinical activity relates to the vaccination of patients with a history – old or recent – of acute myopericarditis. Even though data on this subject are, at present, even scarcer, the Commission recommends, particularly in the context of recent acute myocarditis, that: (a) this population group should not be excluded from vaccination policies; (b) principally in the context of the second vaccine dose, it should be given with one of the two nationally available viral vector formulations – ChAdOx1 (AstraZeneca-Oxford) or Ad26.COV2.S (Johnson & Johnson/Janssen) – even if the first dose had been one using the new mRNA technology.<a class="elsevierStyleCrossRefs" href="#bib0650">64–66</a>Conflicts of interestThe authors have no conflicts of interest to declare." "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres1843901" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1606520" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1843902" "titulo" => "Resumo" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1606521" "titulo" => "Palavras-chave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Probability of occurrence" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Pathophysiological bases" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Diagnosis, treatment and prognosis" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Comparison with the risk of severe SARS-CoV-2 infection" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Conclusion and future prospects" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Conflicts of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2022-02-04" "fechaAceptado" => "2022-02-22" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1606520" "palabras" => array:6 [ 0 => "Acute myocarditis" 1 => "Acute pericarditis" 2 => "SARS-CoV-2" 3 => "COVID-19" 4 => "Vaccination" 5 => "Messenger RNA" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec1606521" "palabras" => array:6 [ 0 => "Miocardite aguda" 1 => "Pericardite aguda" 2 => "SARS-CoV-2" 3 => "Covid-19" 4 => "Vacinação" 5 => "RNA Mensageiro" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "Acute myocarditis (especially) and pericarditis have been consistently associated with the administration of vaccines against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), generating anxiety in the general population, uncertainty in the scientific community and obstacles to ambitious mass vaccination programs, especially in foreign countries.Like some of its European counterparts, the Portuguese Society of Cardiology (SPC), through its Studies Committee, decided to take a position on some of the most pressing questions related to this issue: (i) How certain are we of this epidemiological association? (ii) What is the probability of its occurrence? (iii) What are the pathophysiological bases of these inflammatory syndromes? (iv) Should their diagnosis, treatment and prognosis follow the same steps as for typical idiopathic or post-viral acute myopericarditis cases? (v) Is the risk of post-vaccine myocarditis great enough to overshadow the occurrence of serious COVID-19 disease in unvaccinated individuals? In addition, the SPC will issue clinical recommendations and offer its outlook on the various paths this emerging disease may take in the future." ] "pt" => array:2 [ "titulo" => "Resumo" "resumen" => "Quadros de miocardite (sobretudo) e de pericardite agudas têm vindo a ser consistentemente relacionados com a administração das vacinas anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), gerando ansiedade na população geral, incerteza na comunidade científica e entraves aos ambiciosos programas de vacinação maciça, sobretudo em países estrangeiros.À semelhança de algumas das suas congéneres europeias, pretende a Sociedade Portuguesa de Cardiologia (SPC), por intermédio da sua Comissão de Estudos, tomar posição em relação a algumas da questões mais prementes a si associadas: (i) Quão certos estamos desta associação epidemiológica?; (ii) Qual a probabilidade da sua ocorrência?; (iii) Quais as bases fisiopatológicas destas síndromes inflamatórias?; (iv) Deverão os seus diagnóstico, tratamento e prognóstico seguir os mesmos trâmites dos restantes casos de miopericardite aguda idiopática ou de etiologia pós-vírica?; (v) Será o risco de miocardite pós-vacinal bastante o suficiente a ponto de sobrepujar o da instalação de doença grave por Covid-19 em indivíduos não vacinados? Adicionalmente, serão avançadas recomendações clínicas e perspetivados os diversos trilhos de evolução futura, no respeitante a esta emergente entidade nosológica." ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:66 [ 0 => array:3 [ "identificador" => "bib0335" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N. Barda" 1 => "N. Dagan" 2 => "Y. Ben-Shlomo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "385" "paginaInicial" => "1078" "paginaFinal" => "1090" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0340" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Mevorach" 1 => "E. Anis" 2 => "N. Cedar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2109730" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "385" "paginaInicial" => "2140" "paginaFinal" => "2149" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34614328" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0345" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis after Covid-19 vaccination in a large health care organization" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G. Witberg" 1 => "N. Barda" 2 => "S. Hoss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2110737" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "385" "paginaInicial" => "2132" "paginaFinal" => "2139" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34614329" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0350" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surveillance for adverse events after COVID-19 mRNA vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N.P. Klein" 1 => "N. Lewis" 2 => "K. Goddard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2021.15072" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2021" "volumen" => "326" "paginaInicial" => "1390" "paginaFinal" => "1399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34477808" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0355" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis and pericarditis after vaccination for COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.A. Diaz" 1 => "G.T. Parsons" 2 => "S.K. Gering" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2021.13443" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2021" "volumen" => "326" "paginaInicial" => "1210" "paginaFinal" => "1212" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34347001" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0360" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Montgomery" 1 => "M. Ryan" 2 => "R. Engler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamacardio.2021.2833" "Revista" => array:6 [ "tituloSerie" => "JAMA Cardiol" "fecha" => "2021" "volumen" => "6" "paginaInicial" => "1202" "paginaFinal" => "1206" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34185045" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0365" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patients with acute myocarditis following mRNA COVID-19 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H.W. Kim" 1 => "E.R. Jenista" 2 => "D.C. Wendell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamacardio.2021.2828" "Revista" => array:6 [ "tituloSerie" => "JAMA Cardiol" "fecha" => "2021" "volumen" => "6" "paginaInicial" => "1196" "paginaFinal" => "1201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34185046" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0370" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Dionne" 1 => "F. Sperotto" 2 => "S. Chamberlain" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamacardio.2021.3471" "Revista" => array:6 [ "tituloSerie" => "JAMA Cardiol" "fecha" => "2021" "volumen" => "6" "paginaInicial" => "1446" "paginaFinal" => "1450" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34374740" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0375" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Simone" 1 => "J. Herald" 2 => "A. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamainternmed.2021.5511" "Revista" => array:6 [ "tituloSerie" => "JAMA Intern Med" "fecha" => "2021" "volumen" => "181" "paginaInicial" => "1668" "paginaFinal" => "1670" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34605853" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0380" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of COVID-19 vaccine type and adverse effects following vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.L. Beatty" 1 => "N.D. Peyser" 2 => "X.E. Butcher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "JAMA Netw Open" "fecha" => "2021" "volumen" => "4" "paginaInicial" => "e2140364" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0385" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Husby" 1 => "J.V. Hansen" 2 => "E. Fosbøl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj-2021-068665" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2021" "volumen" => "375" "paginaInicial" => "e068665" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34916207" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0390" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Patone" 1 => "X.W. Mei" 2 => "L. Handunnetthi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41591-021-01630-0" "Revista" => array:6 [ "tituloSerie" => "Nat Med" "fecha" => "2022" "volumen" => "28" "paginaInicial" => "410" "paginaFinal" => "422" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34907393" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0395" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis temporally associated with COVID-19 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "C.M. Rosner" 1 => "L. Genovese" 2 => "B.N. Tehrani" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "2021" "volumen" => "144" "paginaInicial" => "502" "paginaFinal" => "505" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0400" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis after BNT162b2 and mRNA-1273 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "K.F. Larson" 1 => "E. Ammirati" 2 => "E.D. Adler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.121.055913" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2021" "volumen" => "144" "paginaInicial" => "506" "paginaFinal" => "508" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34133884" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0405" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.T. Truong" 1 => "A. Dionne" 2 => "J.C. Muniz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.121.056583" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2022" "volumen" => "145" "paginaInicial" => "345" "paginaFinal" => "356" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34865500" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0410" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis following COVID-19 vaccination – a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Levin" 1 => "G. Shimon" 2 => "M. Fadlon-Derai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.vaccine.2021.09.004" "Revista" => array:6 [ "tituloSerie" => "Vaccine" "fecha" => "2021" "volumen" => "39" "paginaInicial" => "6195" "paginaFinal" => "6200" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34535317" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0415" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis following COVID-19 mRNA vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Abu Mouch" 1 => "A. Roguin" 2 => "E. Hellou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.vaccine.2021.05.087" "Revista" => array:6 [ "tituloSerie" => "Vaccine" "fecha" => "2021" "volumen" => "39" "paginaInicial" => "3790" "paginaFinal" => "3793" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34092429" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0420" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Marshall" 1 => "I.D. Ferguson" 2 => "P. Lewis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Pediatrics" "fecha" => "2021" "volumen" => "148" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0425" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Schauer" 1 => "S. Buddhe" 2 => "J. Colyer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jpeds.2021.06.083" "Revista" => array:6 [ "tituloSerie" => "J Pediatr" "fecha" => "2021" "volumen" => "238" "paginaInicial" => "317" "paginaFinal" => "320" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34228985" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0430" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B.B. Das" 1 => "U. Kohli" 2 => "P. Ramachandran" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Pediatr" "fecha" => "2021" "volumen" => "238" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0435" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: a comparison of completeness and timeliness of two methods" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "K.A. Sharff" 1 => "D.M. Dancoes" 2 => "J.L. Longueil" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1101/2021.12.21.21268209" "Revista" => array:2 [ "tituloSerie" => "medRxiv [preprint]" "fecha" => "2021" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0440" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S.A. Buchan" 1 => "C.Y. Seo" 2 => "C. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1101/2021.12.02.21267156" "Revista" => array:2 [ "tituloSerie" => "medRxiv [preprint]" "fecha" => "2021" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0445" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified National Database Analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.B. Høeg" 1 => "A. Krug" 2 => "J. Stevenson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1101/2021.08.30.21262866" "Revista" => array:2 [ "tituloSerie" => "medRxiv [preprint]" "fecha" => "2021" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0450" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronavirus disease 2019 (COVID-19) vaccines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Centers for Disease Control and Prevention (CDC)" 1 => "Advisory Committee on Immunization Practices (ACIP)" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2021" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0455" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices – United States, June 2021" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.W. Gargano" 1 => "M. Wallace" 2 => "S.C. Hadler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm7027e2" "Revista" => array:6 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2021" "volumen" => "70" "paginaInicial" => "977" "paginaFinal" => "982" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34237049" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0460" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis with COVID-19 mRNA vaccines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Bozkurt" 1 => "I. Kamat" 2 => "P.J. Hotez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.121.056135" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2021" "volumen" => "144" "paginaInicial" => "471" "paginaFinal" => "484" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34281357" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0465" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.T. Shimabukuro" 1 => "M. Nguyen" 2 => "D. Martin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.vaccine.2015.07.035" "Revista" => array:6 [ "tituloSerie" => "Vaccine" "fecha" => "2015" "volumen" => "33" "paginaInicial" => "4398" "paginaFinal" => "4405" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26209838" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0470" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between COVID-19 and myocarditis using hospital-based administrative data – United States, March 2020–January 2021" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.K. Boehmer" 1 => "L. Kompaniyets" 2 => "A.M. Lavery" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm7035e5" "Revista" => array:6 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2021" "volumen" => "70" "paginaInicial" => "1228" "paginaFinal" => "1232" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34473684" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0475" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.R. Su" 1 => "M.M. McNeil" 2 => "K.J. Welsh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.vaccine.2020.12.046" "Revista" => array:6 [ "tituloSerie" => "Vaccine" "fecha" => "2021" "volumen" => "39" "paginaInicial" => "839" "paginaFinal" => "845" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33422381" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0480" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Vojdani" 1 => "D. Kharrazian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clim.2020.108480" "Revista" => array:5 [ "tituloSerie" => "Clin Immunol" "fecha" => "2020" "volumen" => "217" "paginaInicial" => "108480" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32461193" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0485" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Heymans" 1 => "L.T. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Nat Rev Cardiol" "fecha" => "2021" "paginaInicial" => "1" "paginaFinal" => "3" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0490" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Tontsch" 1 => "S. Pankuweit" 2 => "B. Maisch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1365-2249.2000.01283.x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Immunol" "fecha" => "2000" "volumen" => "121" "paginaInicial" => "270" "paginaFinal" => "274" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10931141" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0495" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The quest for new approaches in myocarditis and inflammatory cardiomyopathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Heymans" 1 => "U. Eriksson" 2 => "J. Lehtonen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2016.09.937" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2016" "volumen" => "68" "paginaInicial" => "2348" "paginaFinal" => "2364" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27884253" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0500" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sex differences in inflammation, redox biology, mitochondria and autoimmunity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.N. Di Florio" 1 => "J. Sin" 2 => "M.J. Coronado" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.redox.2020.101482" "Revista" => array:5 [ "tituloSerie" => "Redox Biol" "fecha" => "2020" "volumen" => "31" "paginaInicial" => "101482" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32197947" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0505" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S.A. Huber" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Virology" "fecha" => "2008" "volumen" => "378" "paginaInicial" => "292" "paginaFinal" => "298" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0510" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Age-associated changes in estrogen receptor ratios correlate with increased female susceptibility to Coxsackievirus B3-induced myocarditis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Koenig" 1 => "I. Buskiewicz" 2 => "S.A. Huber" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2017.01585" "Revista" => array:5 [ "tituloSerie" => "Front Immunol" "fecha" => "2017" "volumen" => "8" "paginaInicial" => "1585" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29201031" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0515" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B. Siripanthong" 1 => "S. Nazarian" 2 => "D. Muser" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Heart Rhythm" "fecha" => "2020" "volumen" => "17" "paginaInicial" => "1463" "paginaFinal" => "1471" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0520" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Haaf" 1 => "G.M. Kuster" 2 => "C. Mueller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4414/smw.2021.w30087" "Revista" => array:5 [ "tituloSerie" => "Swiss Med Wkly" "fecha" => "2021" "volumen" => "151" "paginaInicial" => "w30087" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34668687" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0525" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Ammirati" 1 => "M. Frigerio" 2 => "E.D. Adler" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Circ Heart Fail" "fecha" => "2020" "volumen" => "13" "paginaInicial" => "e007405" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0530" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.A. McDonagh" 1 => "M. Metra" 2 => "M. Adamo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehab368" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2021" "volumen" => "42" "paginaInicial" => "3599" "paginaFinal" => "3726" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34447992" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0535" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "Y. Adler" 1 => "P. Charron" 2 => "M. Imazio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Heart J" "fecha" => "2015" "volumen" => "36" "paginaInicial" => "2921" "paginaFinal" => "2964" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0540" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Abbate" 1 => "J. Gavin" 2 => "N. Madanchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijcard.2021.08.018" "Revista" => array:6 [ "tituloSerie" => "Int J Cardiol" "fecha" => "2021" "volumen" => "340" "paginaInicial" => "119" "paginaFinal" => "121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34416319" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0545" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postmortem investigation of fatalities following vaccination with COVID-19 vaccines" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Schneider" 1 => "L. Sottmann" 2 => "A. Greinacher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00414-021-02706-9" "Revista" => array:6 [ "tituloSerie" => "Int J Legal Med" "fecha" => "2021" "volumen" => "135" "paginaInicial" => "2335" "paginaFinal" => "2345" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34591186" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0550" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global perspective of COVID-19 epidemiology for a full-cycle pandemic" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.P.A. Ioannidis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2020" "volumen" => "50" "paginaInicial" => "e13423" ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0555" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 vaccines for children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.S. Gerber" 1 => "P.A. Offit" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.abn2566" "Revista" => array:5 [ "tituloSerie" => "Science" "fecha" => "2021" "volumen" => "374" "paginaInicial" => "913" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34793207" "web" => "Medline" ] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0560" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G. Grasselli" 1 => "M. Greco" 2 => "A. Zanella" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamainternmed.2020.3539" "Revista" => array:6 [ "tituloSerie" => "JAMA Intern Med" "fecha" => "2020" "volumen" => "180" "paginaInicial" => "1345" "paginaFinal" => "1355" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32667669" "web" => "Medline" ] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0565" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aging in COVID-19: vulnerability, immunity and intervention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "Y. Chen" 1 => "S.L. Klein" 2 => "B.T. Garibaldi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arr.2020.101205" "Revista" => array:5 [ "tituloSerie" => "Ageing Res Rev" "fecha" => "2021" "volumen" => "65" "paginaInicial" => "101205" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33137510" "web" => "Medline" ] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0570" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Striking similarities of multisystem inflammatory syndrome in children and a myocarditis-like syndrome in adults: overlapping manifestations of COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "Z.M. Most" 1 => "N. Hendren" 2 => "M.H. Drazner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "2021" "volumen" => "143" "paginaInicial" => "4" "paginaFinal" => "6" ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0575" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long COVID-19 or post-acute sequelae of SARS-CoV-2 infection in children, adolescents, and young adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.R. Hageman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediatr Ann" "fecha" => "2021" "volumen" => "50" "paginaInicial" => "e232" "paginaFinal" => "e233" ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0580" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of COVID-19 related myocarditis: insights on management and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "K. Sawalha" 1 => "M. Abozenah" 2 => "A.J. Kadado" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.carrev.2020.08.028" "Revista" => array:6 [ "tituloSerie" => "Cardiovasc Revasc Med" "fecha" => "2021" "volumen" => "23" "paginaInicial" => "107" "paginaFinal" => "113" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32847728" "web" => "Medline" ] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0585" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronavirus-induced myocarditis: a meta-summary of cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.S. Ho" 1 => "C.H. Sia" 2 => "M.Y. Chan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hrtlng.2020.08.013" "Revista" => array:6 [ "tituloSerie" => "Heart Lung" "fecha" => "2020" "volumen" => "49" "paginaInicial" => "681" "paginaFinal" => "685" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32861884" "web" => "Medline" ] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0590" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review of COVID-19 and myocarditis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.T. Kariyanna" 1 => "B. Sutarjono" 2 => "E. Grewal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Med Case Rep" "fecha" => "2020" "volumen" => "8" "paginaInicial" => "299" "paginaFinal" => "305" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32747875" "web" => "Medline" ] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0595" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Esposito" 1 => "A. Palmisano" 2 => "L. Natale" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcmg.2020.06.003" "Revista" => array:6 [ "tituloSerie" => "JACC Cardiovasc Imaging" "fecha" => "2020" "volumen" => "13" "paginaInicial" => "2462" "paginaFinal" => "2465" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32654966" "web" => "Medline" ] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0600" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F.P. Polack" 1 => "S.J. Thomas" 2 => "N. Kitchin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "N Engl J Med" "fecha" => "2020" "volumen" => "383" "paginaInicial" => "2603" "paginaFinal" => "2615" ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0605" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.R. Baden" 1 => "H.M. El Sahly" 2 => "B. Essink" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2035389" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "384" "paginaInicial" => "403" "paginaFinal" => "416" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33378609" "web" => "Medline" ] ] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0610" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 vaccine safety in adolescents aged 12–17 years – United States, December 14, 2020–July 16, 2021" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.M. Hause" 1 => "J. Gee" 2 => "J. Baggs" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm7031e1" "Revista" => array:6 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2021" "volumen" => "70" "paginaInicial" => "1053" "paginaFinal" => "1058" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34351881" "web" => "Medline" ] ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0615" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Gurdasani" 1 => "S. Bhatt" 2 => "A. Costello" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/01410768211052589" "Revista" => array:6 [ "tituloSerie" => "J R Soc Med" "fecha" => "2021" "volumen" => "114" "paginaInicial" => "513" "paginaFinal" => "524" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34723680" "web" => "Medline" ] ] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0620" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people “as a precaution”" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Paterlini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.n2477" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2021" "volumen" => "375" "paginaInicial" => "n2477" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34635488" "web" => "Medline" ] ] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0625" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 vaccine safety in children aged 5–11 years – United States, November 3–December 19, 2021" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.M. Hause" 1 => "J. Baggs" 2 => "P. Marquez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm705152a1" "Revista" => array:6 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2021" "volumen" => "70" "paginaInicial" => "1755" "paginaFinal" => "1760" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34968370" "web" => "Medline" ] ] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0630" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protection against Covid-19 by BNT162b2 booster across age groups" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "Y.M. Bar-On" 1 => "Y. Goldberg" 2 => "M. Mandel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2115926" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "385" "paginaInicial" => "2421" "paginaFinal" => "2430" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34879188" "web" => "Medline" ] ] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0635" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.M. Herzog" 1 => "O.F. Norheim" 2 => "E.J. Emanuel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.m4853" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2021" "volumen" => "372" "paginaInicial" => "m4853" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33402340" "web" => "Medline" ] ] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0640" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emergence of new SARS-CoV-2 variant of concern omicron (B.1.1.529) – highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Petersen" 1 => "F. Ntoumi" 2 => "D.S. Hui" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijid.2021.11.040" "Revista" => array:6 [ "tituloSerie" => "Int J Infect Dis" "fecha" => "2022" "volumen" => "114" "paginaInicial" => "268" "paginaFinal" => "272" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34863925" "web" => "Medline" ] ] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0645" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Omicron threat remains fuzzy as cases explode" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Kupferschmidt" 1 => "G. Vogel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.acz9928" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2022" "volumen" => "375" "paginaInicial" => "9" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34990256" "web" => "Medline" ] ] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0650" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R.H. Shaw" 1 => "A. Stuart" 2 => "M. Greenland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(21)01158-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2021" "volumen" => "397" "paginaInicial" => "2043" "paginaFinal" => "2046" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34022146" "web" => "Medline" ] ] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0655" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Schmidt" 1 => "V. Klemis" 2 => "D. Schub" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41591-021-01464-w" "Revista" => array:6 [ "tituloSerie" => "Nat Med" "fecha" => "2021" "volumen" => "27" "paginaInicial" => "1530" "paginaFinal" => "1535" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34312554" "web" => "Medline" ] ] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0660" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.S.V. Stuart" 1 => "R.H. Shaw" 2 => "X. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(21)02718-5" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2022" "volumen" => "399" "paginaInicial" => "36" "paginaFinal" => "49" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34883053" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08702551/0000004200000002/v1_202302081302/S0870255123000173/v1_202302081302/en/main.assets" "Apartado" => array:4 [ "identificador" => "93365" "tipo" => "SECCION" "pt" => array:2 [ "titulo" => "State of the Art" "idiomaDefecto" => true ] "idiomaDefecto" => "pt" ] "PDF" => "https://static.elsevier.es/multimedia/08702551/0000004200000002/v1_202302081302/S0870255123000173/v1_202302081302/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255123000173?idApp=UINPBA00004E"]

Estatísticas

State of the Art

Miocardite induzida pela vacinação anti-SARS-CoV-2 – Real, mas, em geral, rara e ligeira: tomada de posição por parte da comissão de estudos da Sociedade Portuguesa de Cardiologia

José Pedro Sousaa,

Autor para correspondência

zpedro_14@hotmail.com

Corresponding author.

, David Roqueb, Cláudio Guerreiroc, Rogério Teixeiraa, on behalf of the Studies Committee of the Portuguese Society of Cardiology

a Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal

b Hospital Prof. Doutor Fernando Fonseca, EPE, Amadora, Portugal

c Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal

Lido

2112

Vezes
que se leu este artigo

766

Total PDF

1346

Total HTML

Compartilhar estatísticas

 array:24 [
  "pii" => "S0870255123000173"
  "issn" => "08702551"
  "doi" => "10.1016/j.repc.2023.01.003"
  "estado" => "S300"
  "fechaPublicacion" => "2023-02-01"
  "aid" => "2092"
  "copyright" => "Sociedade Portuguesa de Cardiologia"
  "copyrightAnyo" => "2023"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "rev"
  "cita" => "Rev Port Cardiol. 2023;42:161-7"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S087025512200525X"
    "issn" => "08702551"
    "doi" => "10.1016/j.repc.2022.12.007"
    "estado" => "S300"
    "fechaPublicacion" => "2023-02-01"
    "aid" => "2081"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Rev Port Cardiol. 2023;42:169&#46;e1-169&#46;e4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Inflammatory myofibroblastic tumor&#58; A rare entity with a complex diagnosis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "169&#46;e1"
          "paginaFinal" => "169&#46;e4"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 400
              "Ancho" => 1005
              "Tamanyo" => 66910
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Coronal view of thoraco-abdominal computed tomography scan before the first surgery&#46; A left atrial tumor is observed extending into the right inferior pulmonary vein outlet&#59; &#40;B&#41; mass resected during the first surgery&#44; elastic in consistency with protuberant characteristics and mother-of-pearl surface color&#46; Part of the interatrial septum can be observed at its base&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Carlos Dom&#237;nguez-Massa, Luc&#237;a Do&#241;ate-Bertol&#237;n, &#211;scar R&#46; Blanco-Herrera, Tom&#225;s Heredia-Cambra, Manuel P&#233;rez-Guill&#233;n, Vicent Mart&#237;nez-C&#243;zar, Empar Mayordomo-Aranda, Fernando Hornero-Sos"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Carlos"
              "apellidos" => "Dom&#237;nguez-Massa"
            ]
            1 => array:2 [
              "nombre" => "Luc&#237;a"
              "apellidos" => "Do&#241;ate-Bertol&#237;n"
            ]
            2 => array:2 [
              "nombre" => "&#211;scar R&#46;"
              "apellidos" => "Blanco-Herrera"
            ]
            3 => array:2 [
              "nombre" => "Tom&#225;s"
              "apellidos" => "Heredia-Cambra"
            ]
            4 => array:2 [
              "nombre" => "Manuel"
              "apellidos" => "P&#233;rez-Guill&#233;n"
            ]
            5 => array:2 [
              "nombre" => "Vicent"
              "apellidos" => "Mart&#237;nez-C&#243;zar"
            ]
            6 => array:2 [
              "nombre" => "Empar"
              "apellidos" => "Mayordomo-Aranda"
            ]
            7 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Hornero-Sos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S087025512200525X?idApp=UINPBA00004E"
    "url" => "/08702551/0000004200000002/v1_202302081302/S087025512200525X/v1_202302081302/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0870255122005248"
    "issn" => "08702551"
    "doi" => "10.1016/j.repc.2022.12.006"
    "estado" => "S300"
    "fechaPublicacion" => "2023-02-01"
    "aid" => "2080"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "dis"
    "cita" => "Rev Port Cardiol. 2023;42:157-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>"
      "titulo" => "Three-dimensional transesophageal echocardiography &#8211; An added value tool for the assessment of aortic plaques in ischemic stroke"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "157"
          "paginaFinal" => "159"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Ecocardiografia transesof&#225;gica 3D &#8211; uma ferramenta de valor acrescentado para a avalia&#231;&#227;o de placas a&#243;rticas no acidente vascular cerebral isqu&#233;mico"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; Ribeiro"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "Ribeiro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255122005248?idApp=UINPBA00004E"
    "url" => "/08702551/0000004200000002/v1_202302081302/S0870255122005248/v1_202302081302/en/main.assets"
  ]
  "en" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">State of the Art</span>"
    "titulo" => "Anti-SARS-CoV-2 vaccine-induced myocarditis &#8211; real but&#44; in general&#44; rare and mild&#58; A consensus statement from the Studies Committee of the Portuguese Society of Cardiology"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "161"
        "paginaFinal" => "167"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Jos&#233; Pedro Sousa, David Roque, Cl&#225;udio Guerreiro, Rog&#233;rio Teixeira"
        "autores" => array:5 [
          0 => array:4 [
            "nombre" => "Jos&#233; Pedro"
            "apellidos" => "Sousa"
            "email" => array:1 [
              0 => "zpedro_14@hotmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "David"
            "apellidos" => "Roque"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Cl&#225;udio"
            "apellidos" => "Guerreiro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Rog&#233;rio"
            "apellidos" => "Teixeira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          4 => array:1 [
            "colaborador" => "on behalf of the Studies Committee of the Portuguese Society of Cardiology"
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Centro Hospitalar e Universit&#225;rio de Coimbra&#44; EPE&#44; Coimbra&#44; Portugal"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Hospital Prof&#46; Doutor Fernando Fonseca&#44; EPE&#44; Amadora&#44; Portugal"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Centro Hospitalar de Vila Nova de Gaia&#47;Espinho&#44; EPE&#44; Vila Nova de Gaia&#44; Portugal"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "Miocardite induzida pela vacina&#231;&#227;o anti-SARS-CoV-2 &#8211; Real&#44; mas&#44; em geral&#44; rara e ligeira&#58; tomada de posi&#231;&#227;o por parte da comiss&#227;o de estudos da Sociedade Portuguesa de Cardiologia"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The evidence currently pointing to an association between vaccination against COVID-19 &#40;coronavirus disease 2019&#41; and the onset of inflammatory heart disease &#8211; principally acute myocarditis&#44; but also acute pericarditis &#8211; is&#44; in our view&#44; unequivocal&#46; Many case series from different continents have been published in some of the most important peer-reviewed journals&#44; including the <span class="elsevierStyleItalic">New England Journal of Medicine</span> &#40;NEJM&#41;&#44;<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">1&#8211;3</span></a> the <span class="elsevierStyleItalic">Journal of the American Medical Association</span> &#40;JAMA&#41;&#44;<a class="elsevierStyleCrossRefs" href="#bib0350"><span class="elsevierStyleSup">4&#44;5</span></a> including <span class="elsevierStyleItalic">JAMA Cardiology</span>&#44;<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">6&#8211;8</span></a><span class="elsevierStyleItalic">JAMA Internal Medicine</span><a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">9</span></a> and <span class="elsevierStyleItalic">JAMA Network Open</span>&#44;<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">10</span></a> the <span class="elsevierStyleItalic">British Medical Journal</span> &#40;BMJ&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">11</span></a><span class="elsevierStyleItalic">Nature Medicine</span>&#44;<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a><span class="elsevierStyleItalic">Circulation</span>&#44;<a class="elsevierStyleCrossRefs" href="#bib0395"><span class="elsevierStyleSup">13&#8211;15</span></a><span class="elsevierStyleItalic">Vaccine</span>&#44;<a class="elsevierStyleCrossRefs" href="#bib0410"><span class="elsevierStyleSup">16&#44;17</span></a><span class="elsevierStyleItalic">Pediatrics</span><a class="elsevierStyleCrossRef" href="#bib0420"><span class="elsevierStyleSup">18</span></a> and the <span class="elsevierStyleItalic">Journal of Pediatrics</span>&#46;<a class="elsevierStyleCrossRefs" href="#bib0425"><span class="elsevierStyleSup">19&#44;20</span></a> Additionally&#44; many others have been pre-published&#46;<a class="elsevierStyleCrossRefs" href="#bib0435"><span class="elsevierStyleSup">21&#8211;23</span></a> Furthermore&#44; since as early as July last year&#44; the Advisory Committee on Immunization Practices &#40;ACIP&#41; of the US Centers for Disease Control and Prevention &#40;CDC&#41; had deemed the existence of a causal relationship between anti-SARS-CoV-2 vaccination and the recurring reports of acute myocarditis and pericarditis syndromes as &#8220;probable&#8221;&#46;<a class="elsevierStyleCrossRefs" href="#bib0450"><span class="elsevierStyleSup">24&#8211;26</span></a> For this appraisal&#44; it made use of the Vaccine Adverse Event Reporting System &#40;VAERS&#41; database and&#44; in particular&#44; the Vaccine Safety Datalink &#40;VSD&#41;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> system&#46; Although it has traditionally been associated with low specificity&#44; generating hypotheses &#40;safety signs&#41; rather than confirming them&#44;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">27</span></a> the concern is now that this database may be underestimating the actual cases of acute myocarditis induced by anti-COVID-19 vaccines&#46;<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">21</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In addition to the quantity and diversity of information sources and publications&#44; this link between anti-SARS-CoV-2 vaccines and incident episodes of acute myocarditis is also &#8211; or even primarily &#8211; reinforced by the notable reproducibility of its presentation pattern&#58; &#40;i&#41; rare and stochastic appearance<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">1&#44;2&#44;6&#44;12</span></a>&#59; &#40;ii&#41; higher risk in adolescents and young adults&#44; especially if male<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">2&#44;3&#44;25&#44;28</span></a>&#59; &#40;iii&#41; tendency to occur after the second vaccine dose&#44; especially with messenger RNA &#40;mRNA&#41; technology &#8211; and&#44; among this subgroup&#44; particularly with the mRNA-1273 vaccine &#40;Moderna&#41;&#44; rather than the BNT162b2 vaccine &#40;Pfizer-BioNTech&#41;<a class="elsevierStyleCrossRefs" href="#bib0380"><span class="elsevierStyleSup">10&#8211;12&#44;22</span></a>&#59; &#40;iv&#41; relatively mild clinical manifestations&#44; usually dominated by chest pain and with neither heart failure nor electrical instability<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a>&#59; and &#40;v&#41; rapid recovery in both clinical and laboratory terms&#46;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Moreover&#44; it is not unprecedented for episodes of acute myopericarditis to be causally connected with vaccine-triggered immune responses&#46; In fact&#44; increases in the incidence of such events have been reported in the context of vaccination against hepatitis B&#44; influenza&#44; and historically &#8211; and with higher likelihood &#8211; smallpox&#46;<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">29</span></a> Interestingly&#44; in these studies&#44; a predisposition for the young male population to be affected was also noted&#46; At all events&#44; this emulates the general epidemiological pattern associated with idiopathic myopericarditis&#44; and not just that of iatrogenic etiology&#46;<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Probability of occurrence</span><p id="par0020" class="elsevierStylePara elsevierViewall">Considering the general population&#44; it can be assumed that the risk of post-COVID-19 vaccination acute myocarditis &#40;in particular&#41; and&#47;or pericarditis is very low&#46; For instance&#44; in the NEJM in September 2021&#44; Barda and co-investigators&#44;<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">1</span></a> using data from the largest healthcare provider organization in Israel &#8211; including about 1&#46;7 million people &#40;half unvaccinated and half who received the Pfizer-BioNTech BNT162b2 vaccine&#41; &#8211; reported 2&#46;7 cases of myocarditis per 100<span class="elsevierStyleHsp" style=""></span>000 vaccinated individuals&#46; Additionally&#44; in December 2021&#44; also reporting on an Israeli population sample inoculated with BNT162b2&#44; Mevorach et al&#46;<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">2</span></a> noted the occurrence of only 136 cases of acute myocarditis among more than five million vaccinated individuals&#46; Furthermore&#44; in the same month&#44; Nature Medicine published a paper by Patone and co-workers&#44;<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a> who recorded an incidence of acute myocarditis no greater than one case per 100<span class="elsevierStyleHsp" style=""></span>000 first or second shots of the mRNA-1273 &#40;Moderna&#41; and BNT162b2 &#40;Pfizer-BioNTech&#41; mRNA vaccines among an English population aged 16 years or older&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">However&#44; as stated above&#44; the burden of this inflammatory complication of anti-SARS-CoV-2 vaccination falls asymmetrically on male adolescents and young adults&#44; especially in the setting of the second dose of an mRNA vaccine&#44; and particularly of Moderna&#39;s mRNA-1273 vaccine&#46;<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">2&#44;3&#44;25&#44;28</span></a> An analysis of this group&#39;s specific risk therefore seems appropriate&#46; Firstly&#44; the importance of young age is well documented&#46; For instance&#44; a third study from Israel&#44; also published in the NEJM&#44;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> analyzed about 2&#46;5 million individuals aged 16 years or older who were inoculated at least once with the BNT162b2 vaccine&#46; In this case&#44; rather than the general acute myocarditis incidence of 2&#46;1 cases per 100<span class="elsevierStyleHsp" style=""></span>000 people&#44; a figure of 10&#46;7&#47;100<span class="elsevierStyleHsp" style=""></span>000 would instead be obtained if only individuals aged between 16 and 29 years were considered&#46; In addition&#44; the previously cited paper by Mevorach et al&#46;<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">2</span></a> lends support to the role of male gender as a major predictor of post-vaccine myocarditis&#44; since&#44; after a second dose of the BNT162b2 vaccine&#44; its likelihood was estimated at about 1&#47;26<span class="elsevierStyleHsp" style=""></span>000 in men &#40;maximum of 1&#47;6637 among those aged between 16 and 19 years&#41;&#44; while reaching only 1&#47;218<span class="elsevierStyleHsp" style=""></span>000 in women &#40;1&#47;99<span class="elsevierStyleHsp" style=""></span>853 among those aged between 16 and 19 years&#41;&#46; Moreover&#44; the importance of receiving the second rather than the first dose of a COVID-19 mRNA &#8211; rather than viral vector &#8211; vaccine&#44; in terms of the risk of acute myocarditis&#44; is demonstrated by the study by Patone and co-workers cited above&#46;<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a> In this analysis&#44; among a population under the age of 40 and receiving a second shot&#44; its likelihood was estimated at less than 0&#46;5&#47;100<span class="elsevierStyleHsp" style=""></span>000&#44; about 1&#47;100<span class="elsevierStyleHsp" style=""></span>000 and 1&#46;5&#47;100<span class="elsevierStyleHsp" style=""></span>000 after the administration of the viral vector ChAdOx1 &#40;AstraZeneca-Oxford&#41;&#44; BNT162b2 &#40;Pfizer-BioNTech&#41; and mRNA-1273 &#40;Moderna&#41; vaccines&#44; respectively&#46; Moreover&#44; in a recent publication in the BMJ<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">11</span></a> encompassing about five million Danes aged 12 years or older&#44; the importance of the commercial formulation of the mRNA vaccine became apparent&#58; the rate of acute myocarditis and&#47;or pericarditis cases diagnosed after immunization with the mRNA-1273 vaccine was 6&#46;3 per 100<span class="elsevierStyleHsp" style=""></span>000 men and 2 per 100<span class="elsevierStyleHsp" style=""></span>000 women&#44; whereas the risk attributable to the BNT162b2 vaccine was markedly lower&#44; especially in males&#58; 1&#46;5&#47;100<span class="elsevierStyleHsp" style=""></span>000 in men and 1&#46;3&#47;100<span class="elsevierStyleHsp" style=""></span>000 in women&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Pathophysiological bases</span><p id="par0030" class="elsevierStylePara elsevierViewall">Since the epidemiological association between anti-SARS-CoV-2 mRNA vaccines and acute myocarditis and pericarditis has not only been confirmed but also consistently quantified&#44; it seems natural for research to be carried out directed at the pathophysiology underlying the myopericardial inflammation potentially generated by these vaccines&#46; At the present time&#44; its mechanistic basis remains unknown&#46;<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> Nevertheless&#44; several hypotheses have been raised&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">The most frequently discussed potential pathophysiological process<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;30&#44;31</span></a> is a possible molecular mimicry between the spike protein of SARS-CoV-2 &#8211; the biological target of mRNA vaccines &#8211; and a particular myocardial structural protein&#44; possibly alpha-myosin&#46; It has been postulated that this may lead to cross-reactivity and thence the synthesis of autoantibodies&#44; which may be harmful to tissue containing the relevant antigens &#8211; in this case&#44; the myocardium&#46;<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;30&#44;31</span></a> This rationale &#8211; similar to that previously conceived for the development of rheumatic heart disease after Lancefield group A streptococcus infection<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">32</span></a> &#8211; currently suffers from a lack of laboratory documentation of the theorized cardiac autoantibodies&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Another hypothesis<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">31</span></a> &#8211; not incompatible with the first and&#44; by contrast&#44; already backed by basic research&#44; even though carried out in other settings<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">33&#8211;36</span></a> &#8211; is the possibility of sex hormones exerting differential and even contrasting effects&#46; In this case&#44; the tendency of adolescents and young men to develop post-vaccine myocarditis suggests the possibility of a harmful effect of testosterone&#44; which has previously been repeatedly implicated<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">33&#44;34</span></a> in proinflammatory and poorly adaptive responses&#44; in terms of both injury prevention and repair&#44; at the cardiomyocyte level&#46; By contrast&#44; estrogens have been shown to exert anti-inflammatory effects and to negatively regulate cellular immune responses&#44; mainly in the context of fundamental research undertaken in murine models&#46;<a class="elsevierStyleCrossRefs" href="#bib0505"><span class="elsevierStyleSup">35&#44;36</span></a> More broadly&#44; this theory of hormonal modulation of immunoinflammatory processes could explain why male gender represents a prominent risk factor for many other entities in the spectrum of myocarditis<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">26</span></a> &#8211; and&#44; most importantly&#44; for the most common idiopathic or viral types&#44; which could include that induced by SARS-CoV-2 itself&#46;<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">37</span></a> On the other hand&#44; the proponents of this hypothesis<a class="elsevierStyleCrossRefs" href="#bib0495"><span class="elsevierStyleSup">33&#44;34</span></a> also recognize its main limitation&#58; its inability to explain the apparent cardiac specificity of this biological response&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Finally&#44; and given not only that post-vaccine myocarditis seems to affect a very limited subset of patients &#40;even when all the published studies are grouped and the possibility of reporting underestimation is acknowledged<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">21</span></a>&#41;&#44; who&#44; additionally&#44; tend to recover quickly&#44;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> but also that a specific animal model of the condition is currently unavailable&#44; our real ignorance of its pathophysiological basis is likely to persist&#46;<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">31</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Diagnosis&#44; treatment and prognosis</span><p id="par0050" class="elsevierStylePara elsevierViewall">As mentioned above&#44; the clinical presentation and course of anti-SARS-CoV-2 vaccination-associated myocarditis reveal surprising homogeneity&#44; particularly in its mild intensity and rapid resolution&#44;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> with or without treatment&#44; which is fundamentally supportive&#46;<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">38</span></a> The two largest series published in academic journals to date featuring detailed clinical descriptions are Witberg et al&#46;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> in the NEJM&#44; with 54 patients&#44; and Truong et al&#46;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> in <span class="elsevierStyleItalic">Circulation</span>&#44; with 139&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">With regard to clinical presentation&#44; it is important to highlight that chest pain is by far the most common manifestation&#44; affecting as many as 99&#37; of the patients in the study by Truong et al&#46;&#44;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> and at least 81&#37; in Witberg et al&#46;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> The second most common symptom is fever&#44; followed by dyspnea&#46; These were present in 9&#8211;31&#37; and 6&#8211;27&#37; of these population samples&#44; respectively&#46;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> It therefore comes as a surprise to us that the CDC-endorsed<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">24</span></a> definition of a confirmed case of post-vaccine myocarditis assigns equal value to all cardiac manifestations &#8211; dyspnea&#44; palpitations and syncope as well as chest pain &#8211; and does not even include fever&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Concerning complementary assessment&#44; the electrocardiogram &#40;ECG&#41; is&#44; in this setting&#44; most likely to be altered&#46; Between 70&#37; &#40;in the study by Truong and colleagues<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a>&#41; and 79&#37; &#40;in Witberg et al&#46;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a>&#41; of these exams show significant abnormalities&#44; particularly of the ST segment &#40;especially elevation&#44; reflecting the concomitant presence of acute pericarditis&#41; and of the T wave&#44; which are present in 68&#8211;70&#37; of cases&#46; This naturally bolsters the role of the ECG as a screening tool&#46; In turn&#44; it should be noted that the previously mentioned definition<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">24</span></a> of confirmed post-vaccine myocarditis&#44; as proposed by the CDC&#44; in the absence of histopathological confirmation&#44; requires both elevated troponin and cardiac magnetic resonance imaging &#40;CMRI&#41; findings consistent with myocarditis&#46; The ubiquity of these criteria in the above-mentioned case series<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> is therefore to be expected&#46; Even so&#44; elevations of blood biomarkers of myocardial injury are&#44; as a rule&#44; modest<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> and global left ventricular systolic function is generally preserved&#44; with mean left ventricular ejection fraction &#40;LVEF&#41; as estimated by CMRI of 60&#37; in the study by Truong and colleagues&#46;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> In this analysis&#44; the key anomalies detected by this imaging technique were the presence of late gadolinium enhancement&#44; in 76&#37; of patients&#44; and of myocardial edema&#44; in 56&#37;&#46; Importantly&#44; the Lake Louise criteria for myocarditis were met in only 51&#37;&#46; Truong et al&#46;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> also reported that&#44; on transthoracic echocardiography&#44; only 3&#37; of the sample presented moderate to severe left ventricular systolic dysfunction and only one patient exhibited pericardial effusion&#44; which was small&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Since in this specific context &#40;but also in many others falling within the spectrum of acute myocarditis and chronic inflammatory cardiomyopathy&#41; there have been no randomized controlled clinical trials&#44; nor are there likely to be&#44; assessing patient-centered clinical outcomes&#44;<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">39</span></a> specific treatment cannot be recommended&#46;<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;38</span></a> However&#44; as a rule&#44; conventional pharmacotherapy generally initiated in heart failure settings &#8211; in particular&#44; angiotensin-converting enzyme inhibitors and beta-blockers &#8211; should be considered&#44;<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;38</span></a> and escalation to sacubitril-valsartan&#44; mineralocorticoid receptor antagonists and&#47;or sodium-glucose type 2 co-transporter inhibitors may be performed in cases in which moderate-to-severe left ventricular systolic dysfunction is detected&#46;<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">40</span></a> Of course&#44; the clinical indication for all these agents should be reassessed during follow-up consultation&#46;<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;38</span></a> There is no contraindication to the use of non-steroidal anti-inflammatory drugs<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">26&#44;38</span></a> if LVEF is not reduced&#46; By contrast&#44; immunomodulatory agents &#8211; with the possible exception of colchicine&#44; which is indicated in most cases of associated acute pericarditis<a class="elsevierStyleCrossRefs" href="#bib0520"><span class="elsevierStyleSup">38&#44;41</span></a> &#8211; should be applied cautiously&#46; In particular&#44; intravenous corticosteroids and immunoglobulins should be considered only in the most severe cases&#44; and always on an individual basis&#46;<a class="elsevierStyleCrossRefs" href="#bib0520"><span class="elsevierStyleSup">38&#44;42</span></a> Chest pain can also be addressed with&#44; for example&#44; paracetamol and opioid agents&#44; in addition to the aforementioned non-steroidal anti-inflammatory drugs&#46;<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">38</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">A diagnosis of acute myocarditis mandates hospitalization in the majority of cases&#44; even if its clinical course is expected to be brief and uncomplicated&#46; In this context&#44; Truong et al&#46;<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> report a median of only two days of hospitalization&#46; Therefore&#44; it is not surprising that only two patients in their study<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">15</span></a> and one in that of Witberg and colleagues<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> eventually required pharmacological inotropic or vasopressor support&#46; More importantly&#44; only one patient&#44; reported in the study by Witberg et al&#46;&#44;<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">3</span></a> needed to be rescued with mechanical circulatory support&#44; and none actually died&#46;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> However&#44; it should be noted that other investigators<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">42</span></a> have reported post-COVID-19 vaccine cases of fulminant myocarditis and significant ventricular dysrhythmia&#46; Reassuringly&#44; however&#44; death attributable to these remains an exception&#46;<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">43</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Comparison with the risk of severe SARS-CoV-2 infection</span><p id="par0075" class="elsevierStylePara elsevierViewall">Although&#44; as described above&#44; the risk of acute myocarditis in the context of anti-SARS-CoV-2 vaccination appears to be real&#44; it seems appropriate to compare it with that of severe COVID-19 disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">1&#44;24&#8211;26</span></a> This stems from the fact that the majority of the world&#39;s population is likely&#44; sooner or later&#44; to come into contact with SARS-CoV-2&#46;<a class="elsevierStyleCrossRefs" href="#bib0550"><span class="elsevierStyleSup">44&#44;45</span></a> Thus&#44; the personal option not to be vaccinated should not&#44; in this context&#44; be interpreted as a risk-free strategy&#44; but rather as the personal selection of a different risk&#44;<a class="elsevierStyleCrossRef" href="#bib0555"><span class="elsevierStyleSup">45</span></a> perhaps an even more serious one&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">From early on&#44; the CDC sought to present estimates of the risk-benefit ratio of anti-COVID-19 vaccination&#46;<a class="elsevierStyleCrossRefs" href="#bib0450"><span class="elsevierStyleSup">24&#8211;26</span></a> While it is indisputable that older age groups &#8211; in which the risk of post-vaccine myocarditis is even lower<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">2&#44;3&#44;25&#44;28</span></a> &#8211; have significantly more severe infection-related complications&#44;<a class="elsevierStyleCrossRefs" href="#bib0560"><span class="elsevierStyleSup">46&#44;47</span></a> the CDC&#39;s analysis could have raised doubts in the subgroup that has shown greater predilection toward development of myocarditis&#44; that is&#44; young males&#44;<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">2&#44;3&#44;25&#44;28</span></a> who also happen to be more likely to be spared from severe COVID-19 disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0560"><span class="elsevierStyleSup">46&#44;47</span></a> However&#44; such uncertainty may be resolved through a simple case-by-case analysis of the already published data&#46;<a class="elsevierStyleCrossRefs" href="#bib0450"><span class="elsevierStyleSup">24&#8211;26</span></a> This shows that for every million second doses of anti-SARS-CoV-2 mRNA vaccines administered to this fringe population&#44; 12<span class="elsevierStyleHsp" style=""></span>000 cases of COVID-19 are expected to be prevented&#44; along with 530 hospitalizations&#44; 127 intensive care unit admissions and three deaths&#44; while only 45&#8211;56 cases of acute myocarditis are anticipated to ensue&#46; The study by Barda et al&#46; referred to above<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">1</span></a> also sought to help resolve this dispute&#44; noting that use of the Pfizer-BioNTech BNT162b2 vaccine significantly reduces the risk of numerous other conditions&#44; including acute myocardial infarction&#44; intracranial hemorrhage&#44; pulmonary embolism&#44; deep vein thrombosis&#44; clinically significant dysrhythmia and acute kidney injury&#44; in comparisons between vaccinated and unvaccinated individuals and between infected and uninfected persons&#46; Additionally&#44; other important viral complications&#44; such as systemic inflammatory syndrome in both infants and adults&#44;<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">48</span></a> and post-acute sequelae of the infection in the form of so-called long COVID<a class="elsevierStyleCrossRef" href="#bib0575"><span class="elsevierStyleSup">49</span></a> also appear to be effectively prevented by vaccination&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">On the other hand&#44; a favorable risk-benefit balance of anti-SARS-CoV-2 mRNA vaccination can be immediately inferred just by looking at the condition of acute myocarditis per se&#46; Barda et al&#46;<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">1</span></a> have shown that the probability of this diagnosis increases by a factor of 3&#46;2 after vaccine administration and by 18&#46;3 after COVID-19 infection itself&#46; Additionally&#44; in the study by Patone et al&#46;&#44;<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">12</span></a> with the aforementioned estimate of &#60;1 post-vaccine myocarditis case per 100<span class="elsevierStyleHsp" style=""></span>000 vaccinated individuals&#44; a 4&#47;100<span class="elsevierStyleHsp" style=""></span>000 chance of acute myocarditis was ascribed to the unvaccinated population sample&#46; Furthermore&#44; the clinical consequences of post-vaccine and post-infection myocarditis also appear to differ&#58; while the former&#44; as previously stated&#44;<a class="elsevierStyleCrossRefs" href="#bib0345"><span class="elsevierStyleSup">3&#44;15</span></a> tends to follow a rapid&#44; mild and uncomplicated course&#44; the latter has been associated &#8211; in some<a class="elsevierStyleCrossRefs" href="#bib0580"><span class="elsevierStyleSup">50&#44;51</span></a> but not all<a class="elsevierStyleCrossRefs" href="#bib0590"><span class="elsevierStyleSup">52&#44;53</span></a> reviews on this matter &#8211; with adverse outcomes of various kinds&#44; including death&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusion and future prospects</span><p id="par0090" class="elsevierStylePara elsevierViewall">Based on the currently available scientific evidence&#44; the benefits conferred by anti-SARS-CoV-2 vaccination far outweigh the risks attributed to it&#44;<a class="elsevierStyleCrossRefs" href="#bib0450"><span class="elsevierStyleSup">24&#8211;26</span></a> particularly with regard to acute myocarditis&#46; Thus&#44; as far as the initially recommended scheme for mRNA vaccine rollout &#8211; two doses in all individuals aged 12 years or older<a class="elsevierStyleCrossRefs" href="#bib0600"><span class="elsevierStyleSup">54&#8211;57</span></a> &#8211; is concerned&#44; the Studies Committee of the Portuguese Society of Cardiology recommends its routine use&#46; Although this conflicts with some health policies adopted in northern European countries&#44;<a class="elsevierStyleCrossRef" href="#bib0620"><span class="elsevierStyleSup">58</span></a> it also supports the use of the mRNA-1273 &#40;Moderna&#41; formulation in this setting&#46; In this way&#44; the Committee hopes to contribute decisively to persuading the fringe populations that currently refuse to be vaccinated&#46; Fortunately&#44; regarding the mRNA vaccine rollout in children aged 5&#8211;11 years<a class="elsevierStyleCrossRef" href="#bib0625"><span class="elsevierStyleSup">59</span></a> and as a three-dose strategy&#44;<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">60</span></a> no significant warning signs have thus far been detected&#46; In fact&#44; notwithstanding the rather scant scientific evidence currently at our disposal&#44; the risk of acute myocarditis appears to be even lower in these scenarios&#46; Regarding the former&#44; it seems less than that ascribed to young adults&#44; even in males&#44; thus supporting the previously mentioned hypothesis of hormonal modulation of immune phenomena&#44;<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">31</span></a> while as for the latter&#44; the third dose also appears to pose a lesser threat in this instance&#44; at least compared to the second dose&#46; Of course&#44; these observations should not restrict upcoming research in this area&#46; As a matter of fact&#44; the Committee would push for future studies focusing on the evaluation of even lower vaccine doses and longer inter-vaccine intervals in the population with greater predilection toward development of post-vaccine acute myocarditis&#46; On the other hand&#44; by its conditional endorsement of these childhood and booster vaccination strategies&#44; the Committee does not aim to deny the paramount importance of worldwide anti-SARS-CoV-2 vaccination efforts&#46; In fact&#44; it goes as far as to consider that developing countries should even be favored&#44;<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">61</span></a> as it believes this constitutes the most effective means for stemming the emergence of new variants&#46;<a class="elsevierStyleCrossRef" href="#bib0640"><span class="elsevierStyleSup">62</span></a> It is crucial to bear in mind that these &#8211; of which Omicron naturally currently has a prominent place<a class="elsevierStyleCrossRefs" href="#bib0640"><span class="elsevierStyleSup">62&#44;63</span></a> &#8211; may even demonstrate the ability to impact on the favorable risk-benefit ratio currently attributed to vaccination&#44; at least with regard to its effectiveness&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">Finally&#44; a challenging situation that some Portuguese cardiologists will have to face over the course of their clinical activity relates to the vaccination of patients with a history &#8211; old or recent &#8211; of acute myopericarditis&#46; Even though data on this subject are&#44; at present&#44; even scarcer&#44; the Commission recommends&#44; particularly in the context of recent acute myocarditis&#44; that&#58; &#40;a&#41; this population group should not be excluded from vaccination policies&#59; &#40;b&#41; principally in the context of the second vaccine dose&#44; it should be given with one of the two nationally available viral vector formulations &#8211; ChAdOx1 &#40;AstraZeneca-Oxford&#41; or Ad26&#46;COV2&#46;S &#40;Johnson &#38; Johnson&#47;Janssen&#41; &#8211; even if the first dose had been one using the new mRNA technology&#46;<a class="elsevierStyleCrossRefs" href="#bib0650"><span class="elsevierStyleSup">64&#8211;66</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Conflicts of interest</span><p id="par0100" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:12 [
        0 => array:3 [
          "identificador" => "xres1843901"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1606520"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1843902"
          "titulo" => "Resumo"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1606521"
          "titulo" => "Palavras-chave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Probability of occurrence"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Pathophysiological bases"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Diagnosis&#44; treatment and prognosis"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Comparison with the risk of severe SARS-CoV-2 infection"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conclusion and future prospects"
        ]
        10 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Conflicts of interest"
        ]
        11 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2022-02-04"
    "fechaAceptado" => "2022-02-22"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1606520"
          "palabras" => array:6 [
            0 => "Acute myocarditis"
            1 => "Acute pericarditis"
            2 => "SARS-CoV-2"
            3 => "COVID-19"
            4 => "Vaccination"
            5 => "Messenger RNA"
          ]
        ]
      ]
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras-chave"
          "identificador" => "xpalclavsec1606521"
          "palabras" => array:6 [
            0 => "Miocardite aguda"
            1 => "Pericardite aguda"
            2 => "SARS-CoV-2"
            3 => "Covid-19"
            4 => "Vacina&#231;&#227;o"
            5 => "RNA Mensageiro"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Acute myocarditis &#40;especially&#41; and pericarditis have been consistently associated with the administration of vaccines against SARS-CoV-2 &#40;severe acute respiratory syndrome coronavirus 2&#41;&#44; generating anxiety in the general population&#44; uncertainty in the scientific community and obstacles to ambitious mass vaccination programs&#44; especially in foreign countries&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Like some of its European counterparts&#44; the Portuguese Society of Cardiology &#40;SPC&#41;&#44; through its Studies Committee&#44; decided to take a position on some of the most pressing questions related to this issue&#58; &#40;i&#41; How certain are we of this epidemiological association&#63; &#40;ii&#41; What is the probability of its occurrence&#63; &#40;iii&#41; What are the pathophysiological bases of these inflammatory syndromes&#63; &#40;iv&#41; Should their diagnosis&#44; treatment and prognosis follow the same steps as for typical idiopathic or post-viral acute myopericarditis cases&#63; &#40;v&#41; Is the risk of post-vaccine myocarditis great enough to overshadow the occurrence of serious COVID-19 disease in unvaccinated individuals&#63; In addition&#44; the SPC will issue clinical recommendations and offer its outlook on the various paths this emerging disease may take in the future&#46;</p></span>"
      ]
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Quadros de miocardite &#40;sobretudo&#41; e de pericardite agudas t&#234;m vindo a ser consistentemente relacionados com a administra&#231;&#227;o das vacinas anti-SARS-CoV-2 &#40;<span class="elsevierStyleItalic">Severe Acute Respiratory Syndrome Coronavirus</span> 2&#41;&#44; gerando ansiedade na popula&#231;&#227;o geral&#44; incerteza na comunidade cient&#237;fica e entraves aos ambiciosos programas de vacina&#231;&#227;o maci&#231;a&#44; sobretudo em pa&#237;ses estrangeiros&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">&#192; semelhan&#231;a de algumas das suas cong&#233;neres europeias&#44; pretende a Sociedade Portuguesa de Cardiologia &#40;SPC&#41;&#44; por interm&#233;dio da sua Comiss&#227;o de Estudos&#44; tomar posi&#231;&#227;o em rela&#231;&#227;o a algumas da quest&#245;es mais prementes a si associadas&#58; &#40;i&#41; Qu&#227;o certos estamos desta associa&#231;&#227;o epidemiol&#243;gica&#63;&#59; &#40;ii&#41; Qual a probabilidade da sua ocorr&#234;ncia&#63;&#59; &#40;iii&#41; Quais as bases fisiopatol&#243;gicas destas s&#237;ndromes inflamat&#243;rias&#63;&#59; &#40;iv&#41; Dever&#227;o os seus diagn&#243;stico&#44; tratamento e progn&#243;stico seguir os mesmos tr&#226;mites dos restantes casos de miopericardite aguda idiop&#225;tica ou de etiologia p&#243;s-v&#237;rica&#63;&#59; &#40;v&#41; Ser&#225; o risco de miocardite p&#243;s-vacinal bastante o suficiente a ponto de sobrepujar o da instala&#231;&#227;o de doen&#231;a grave por Covid-19 em indiv&#237;duos n&#227;o vacinados&#63; Adicionalmente&#44; ser&#227;o avan&#231;adas recomenda&#231;&#245;es cl&#237;nicas e perspetivados os diversos trilhos de evolu&#231;&#227;o futura&#44; no respeitante a esta emergente entidade nosol&#243;gica&#46;</p></span>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:66 [
            0 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "N&#46; Barda"
                            1 => "N&#46; Dagan"
                            2 => "Y&#46; Ben-Shlomo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2021"
                        "volumen" => "385"
                        "paginaInicial" => "1078"
                        "paginaFinal" => "1090"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46; Mevorach"
                            1 => "E&#46; Anis"
                            2 => "N&#46; Cedar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa2109730"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2021"
                        "volumen" => "385"
                        "paginaInicial" => "2140"
                        "paginaFinal" => "2149"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34614328"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis after Covid-19 vaccination in a large health care organization"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "G&#46; Witberg"
                            1 => "N&#46; Barda"
                            2 => "S&#46; Hoss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa2110737"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2021"
                        "volumen" => "385"
                        "paginaInicial" => "2132"
                        "paginaFinal" => "2139"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34614329"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Surveillance for adverse events after COVID-19 mRNA vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "N&#46;P&#46; Klein"
                            1 => "N&#46; Lewis"
                            2 => "K&#46; Goddard"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2021.15072"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "2021"
                        "volumen" => "326"
                        "paginaInicial" => "1390"
                        "paginaFinal" => "1399"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34477808"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis and pericarditis after vaccination for COVID-19"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "G&#46;A&#46; Diaz"
                            1 => "G&#46;T&#46; Parsons"
                            2 => "S&#46;K&#46; Gering"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2021.13443"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "2021"
                        "volumen" => "326"
                        "paginaInicial" => "1210"
                        "paginaFinal" => "1212"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34347001"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46; Montgomery"
                            1 => "M&#46; Ryan"
                            2 => "R&#46; Engler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamacardio.2021.2833"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Cardiol"
                        "fecha" => "2021"
                        "volumen" => "6"
                        "paginaInicial" => "1202"
                        "paginaFinal" => "1206"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34185045"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Patients with acute myocarditis following mRNA COVID-19 vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "H&#46;W&#46; Kim"
                            1 => "E&#46;R&#46; Jenista"
                            2 => "D&#46;C&#46; Wendell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamacardio.2021.2828"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Cardiol"
                        "fecha" => "2021"
                        "volumen" => "6"
                        "paginaInicial" => "1196"
                        "paginaFinal" => "1201"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34185046"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46; Dionne"
                            1 => "F&#46; Sperotto"
                            2 => "S&#46; Chamberlain"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamacardio.2021.3471"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Cardiol"
                        "fecha" => "2021"
                        "volumen" => "6"
                        "paginaInicial" => "1446"
                        "paginaFinal" => "1450"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34374740"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46; Simone"
                            1 => "J&#46; Herald"
                            2 => "A&#46; Chen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamainternmed.2021.5511"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Intern Med"
                        "fecha" => "2021"
                        "volumen" => "181"
                        "paginaInicial" => "1668"
                        "paginaFinal" => "1670"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34605853"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Analysis of COVID-19 vaccine type and adverse effects following vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46;L&#46; Beatty"
                            1 => "N&#46;D&#46; Peyser"
                            2 => "X&#46;E&#46; Butcher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "JAMA Netw Open"
                        "fecha" => "2021"
                        "volumen" => "4"
                        "paginaInicial" => "e2140364"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SARS-CoV-2 vaccination and myocarditis or myopericarditis&#58; population based cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46; Husby"
                            1 => "J&#46;V&#46; Hansen"
                            2 => "E&#46; Fosb&#248;l"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj-2021-068665"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2021"
                        "volumen" => "375"
                        "paginaInicial" => "e068665"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34916207"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risks of myocarditis&#44; pericarditis&#44; and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "M&#46; Patone"
                            1 => "X&#46;W&#46; Mei"
                            2 => "L&#46; Handunnetthi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/s41591-021-01630-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Med"
                        "fecha" => "2022"
                        "volumen" => "28"
                        "paginaInicial" => "410"
                        "paginaFinal" => "422"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34907393"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis temporally associated with COVID-19 vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "C&#46;M&#46; Rosner"
                            1 => "L&#46; Genovese"
                            2 => "B&#46;N&#46; Tehrani"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2021"
                        "volumen" => "144"
                        "paginaInicial" => "502"
                        "paginaFinal" => "505"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis after BNT162b2 and mRNA-1273 vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "K&#46;F&#46; Larson"
                            1 => "E&#46; Ammirati"
                            2 => "E&#46;D&#46; Adler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.121.055913"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2021"
                        "volumen" => "144"
                        "paginaInicial" => "506"
                        "paginaFinal" => "508"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34133884"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46;T&#46; Truong"
                            1 => "A&#46; Dionne"
                            2 => "J&#46;C&#46; Muniz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.121.056583"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2022"
                        "volumen" => "145"
                        "paginaInicial" => "345"
                        "paginaFinal" => "356"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34865500"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis following COVID-19 vaccination &#8211; a case series"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46; Levin"
                            1 => "G&#46; Shimon"
                            2 => "M&#46; Fadlon-Derai"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2021.09.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2021"
                        "volumen" => "39"
                        "paginaInicial" => "6195"
                        "paginaFinal" => "6200"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34535317"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis following COVID-19 mRNA vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46; Abu Mouch"
                            1 => "A&#46; Roguin"
                            2 => "E&#46; Hellou"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2021.05.087"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2021"
                        "volumen" => "39"
                        "paginaInicial" => "3790"
                        "paginaFinal" => "3793"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34092429"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "M&#46; Marshall"
                            1 => "I&#46;D&#46; Ferguson"
                            2 => "P&#46; Lewis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Pediatrics"
                        "fecha" => "2021"
                        "volumen" => "148"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46; Schauer"
                            1 => "S&#46; Buddhe"
                            2 => "J&#46; Colyer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jpeds.2021.06.083"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2021"
                        "volumen" => "238"
                        "paginaInicial" => "317"
                        "paginaFinal" => "320"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34228985"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "B&#46;B&#46; Das"
                            1 => "U&#46; Kohli"
                            2 => "P&#46; Ramachandran"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "2021"
                        "volumen" => "238"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system&#58; a comparison of completeness and timeliness of two methods"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "K&#46;A&#46; Sharff"
                            1 => "D&#46;M&#46; Dancoes"
                            2 => "J&#46;L&#46; Longueil"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1101/2021.12.21.21268209"
                      "Revista" => array:2 [
                        "tituloSerie" => "medRxiv &#91;preprint&#93;"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario&#44; Canada&#58; by vaccine product&#44; schedule and interval"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46;A&#46; Buchan"
                            1 => "C&#46;Y&#46; Seo"
                            2 => "C&#46; Johnson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1101/2021.12.02.21267156"
                      "Revista" => array:2 [
                        "tituloSerie" => "medRxiv &#91;preprint&#93;"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12&#8211;17&#58; a stratified National Database Analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46;B&#46; H&#248;eg"
                            1 => "A&#46; Krug"
                            2 => "J&#46; Stevenson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1101/2021.08.30.21262866"
                      "Revista" => array:2 [
                        "tituloSerie" => "medRxiv &#91;preprint&#93;"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coronavirus disease 2019 &#40;COVID-19&#41; vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Centers for Disease Control and Prevention &#40;CDC&#41;"
                            1 => "Advisory Committee on Immunization Practices &#40;ACIP&#41;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients&#58; update from the advisory committee on immunization practices &#8211; United States&#44; June 2021"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;W&#46; Gargano"
                            1 => "M&#46; Wallace"
                            2 => "S&#46;C&#46; Hadler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm7027e2"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2021"
                        "volumen" => "70"
                        "paginaInicial" => "977"
                        "paginaFinal" => "982"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34237049"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis with COVID-19 mRNA vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "B&#46; Bozkurt"
                            1 => "I&#46; Kamat"
                            2 => "P&#46;J&#46; Hotez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.121.056135"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2021"
                        "volumen" => "144"
                        "paginaInicial" => "471"
                        "paginaFinal" => "484"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34281357"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety monitoring in the Vaccine Adverse Event Reporting System &#40;VAERS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46;T&#46; Shimabukuro"
                            1 => "M&#46; Nguyen"
                            2 => "D&#46; Martin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2015.07.035"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2015"
                        "volumen" => "33"
                        "paginaInicial" => "4398"
                        "paginaFinal" => "4405"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26209838"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association between COVID-19 and myocarditis using hospital-based administrative data &#8211; United States&#44; March 2020&#8211;January 2021"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46;K&#46; Boehmer"
                            1 => "L&#46; Kompaniyets"
                            2 => "A&#46;M&#46; Lavery"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm7035e5"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2021"
                        "volumen" => "70"
                        "paginaInicial" => "1228"
                        "paginaFinal" => "1232"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34473684"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myopericarditis after vaccination&#44; Vaccine Adverse Event Reporting System &#40;VAERS&#41;&#44; 1990&#8211;2018"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;R&#46; Su"
                            1 => "M&#46;M&#46; McNeil"
                            2 => "K&#46;J&#46; Welsh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.vaccine.2020.12.046"
                      "Revista" => array:6 [
                        "tituloSerie" => "Vaccine"
                        "fecha" => "2021"
                        "volumen" => "39"
                        "paginaInicial" => "839"
                        "paginaFinal" => "845"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33422381"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46; Vojdani"
                            1 => "D&#46; Kharrazian"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.clim.2020.108480"
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Immunol"
                        "fecha" => "2020"
                        "volumen" => "217"
                        "paginaInicial" => "108480"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32461193"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Myocarditis after COVID-19 mRNA vaccination&#58; clinical observations and potential mechanisms"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46; Heymans"
                            1 => "L&#46;T&#46; Cooper"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Nat Rev Cardiol"
                        "fecha" => "2021"
                        "paginaInicial" => "1"
                        "paginaFinal" => "3"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies in the sera of patients with rheumatic heart disease&#58; characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "D&#46; Tontsch"
                            1 => "S&#46; Pankuweit"
                            2 => "B&#46; Maisch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1046/j.1365-2249.2000.01283.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Immunol"
                        "fecha" => "2000"
                        "volumen" => "121"
                        "paginaInicial" => "270"
                        "paginaFinal" => "274"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10931141"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The quest for new approaches in myocarditis and inflammatory cardiomyopathy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "S&#46; Heymans"
                            1 => "U&#46; Eriksson"
                            2 => "J&#46; Lehtonen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jacc.2016.09.937"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Coll Cardiol"
                        "fecha" => "2016"
                        "volumen" => "68"
                        "paginaInicial" => "2348"
                        "paginaFinal" => "2364"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27884253"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sex differences in inflammation&#44; redox biology&#44; mitochondria and autoimmunity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46;N&#46; Di Florio"
                            1 => "J&#46; Sin"
                            2 => "M&#46;J&#46; Coronado"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.redox.2020.101482"
                      "Revista" => array:5 [
                        "tituloSerie" => "Redox Biol"
                        "fecha" => "2020"
                        "volumen" => "31"
                        "paginaInicial" => "101482"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32197947"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coxsackievirus B3-induced myocarditis&#58; infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "S&#46;A&#46; Huber"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Virology"
                        "fecha" => "2008"
                        "volumen" => "378"
                        "paginaInicial" => "292"
                        "paginaFinal" => "298"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Age-associated changes in estrogen receptor ratios correlate with increased female susceptibility to Coxsackievirus B3-induced myocarditis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Koenig"
                            1 => "I&#46; Buskiewicz"
                            2 => "S&#46;A&#46; Huber"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2017.01585"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol"
                        "fecha" => "2017"
                        "volumen" => "8"
                        "paginaInicial" => "1585"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29201031"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recognizing COVID-19-related myocarditis&#58; the possible pathophysiology and proposed guideline for diagnosis and management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "B&#46; Siripanthong"
                            1 => "S&#46; Nazarian"
                            2 => "D&#46; Muser"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Heart Rhythm"
                        "fecha" => "2020"
                        "volumen" => "17"
                        "paginaInicial" => "1463"
                        "paginaFinal" => "1471"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0520"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "P&#46; Haaf"
                            1 => "G&#46;M&#46; Kuster"
                            2 => "C&#46; Mueller"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4414/smw.2021.w30087"
                      "Revista" => array:5 [
                        "tituloSerie" => "Swiss Med Wkly"
                        "fecha" => "2021"
                        "volumen" => "151"
                        "paginaInicial" => "w30087"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34668687"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0525"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of acute myocarditis and chronic inflammatory cardiomyopathy&#58; an expert consensus document"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "E&#46; Ammirati"
                            1 => "M&#46; Frigerio"
                            2 => "E&#46;D&#46; Adler"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Circ Heart Fail"
                        "fecha" => "2020"
                        "volumen" => "13"
                        "paginaInicial" => "e007405"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0530"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46;A&#46; McDonagh"
                            1 => "M&#46; Metra"
                            2 => "M&#46; Adamo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehab368"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2021"
                        "volumen" => "42"
                        "paginaInicial" => "3599"
                        "paginaFinal" => "3726"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34447992"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0535"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2015 ESC Guidelines for the diagnosis and management of pericardial diseases&#58; the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology &#40;ESC&#41;&#46; Endorsed by&#58; The European Association for Cardio-Thoracic Surgery &#40;EACTS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "Y&#46; Adler"
                            1 => "P&#46; Charron"
                            2 => "M&#46; Imazio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Eur Heart J"
                        "fecha" => "2015"
                        "volumen" => "36"
                        "paginaInicial" => "2921"
                        "paginaFinal" => "2964"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0540"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46; Abbate"
                            1 => "J&#46; Gavin"
                            2 => "N&#46; Madanchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijcard.2021.08.018"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Cardiol"
                        "fecha" => "2021"
                        "volumen" => "340"
                        "paginaInicial" => "119"
                        "paginaFinal" => "121"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34416319"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0545"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Postmortem investigation of fatalities following vaccination with COVID-19 vaccines"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46; Schneider"
                            1 => "L&#46; Sottmann"
                            2 => "A&#46; Greinacher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00414-021-02706-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Legal Med"
                        "fecha" => "2021"
                        "volumen" => "135"
                        "paginaInicial" => "2335"
                        "paginaFinal" => "2345"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34591186"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0550"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global perspective of COVID-19 epidemiology for a full-cycle pandemic"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;P&#46;A&#46; Ioannidis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Eur J Clin Invest"
                        "fecha" => "2020"
                        "volumen" => "50"
                        "paginaInicial" => "e13423"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0555"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19 vaccines for children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46;S&#46; Gerber"
                            1 => "P&#46;A&#46; Offit"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/science.abn2566"
                      "Revista" => array:5 [
                        "tituloSerie" => "Science"
                        "fecha" => "2021"
                        "volumen" => "374"
                        "paginaInicial" => "913"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34793207"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0560"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy&#44; Italy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "G&#46; Grasselli"
                            1 => "M&#46; Greco"
                            2 => "A&#46; Zanella"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamainternmed.2020.3539"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Intern Med"
                        "fecha" => "2020"
                        "volumen" => "180"
                        "paginaInicial" => "1345"
                        "paginaFinal" => "1355"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32667669"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0565"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aging in COVID-19&#58; vulnerability&#44; immunity and intervention"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "Y&#46; Chen"
                            1 => "S&#46;L&#46; Klein"
                            2 => "B&#46;T&#46; Garibaldi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arr.2020.101205"
                      "Revista" => array:5 [
                        "tituloSerie" => "Ageing Res Rev"
                        "fecha" => "2021"
                        "volumen" => "65"
                        "paginaInicial" => "101205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33137510"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0570"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Striking similarities of multisystem inflammatory syndrome in children and a myocarditis-like syndrome in adults&#58; overlapping manifestations of COVID-19"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "Z&#46;M&#46; Most"
                            1 => "N&#46; Hendren"
                            2 => "M&#46;H&#46; Drazner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2021"
                        "volumen" => "143"
                        "paginaInicial" => "4"
                        "paginaFinal" => "6"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0575"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long COVID-19 or post-acute sequelae of SARS-CoV-2 infection in children&#44; adolescents&#44; and young adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;R&#46; Hageman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Pediatr Ann"
                        "fecha" => "2021"
                        "volumen" => "50"
                        "paginaInicial" => "e232"
                        "paginaFinal" => "e233"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0580"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review of COVID-19 related myocarditis&#58; insights on management and outcome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "K&#46; Sawalha"
                            1 => "M&#46; Abozenah"
                            2 => "A&#46;J&#46; Kadado"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.carrev.2020.08.028"
                      "Revista" => array:6 [
                        "tituloSerie" => "Cardiovasc Revasc Med"
                        "fecha" => "2021"
                        "volumen" => "23"
                        "paginaInicial" => "107"
                        "paginaFinal" => "113"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32847728"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0585"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coronavirus-induced myocarditis&#58; a meta-summary of cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;S&#46; Ho"
                            1 => "C&#46;H&#46; Sia"
                            2 => "M&#46;Y&#46; Chan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.hrtlng.2020.08.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Heart Lung"
                        "fecha" => "2020"
                        "volumen" => "49"
                        "paginaInicial" => "681"
                        "paginaFinal" => "685"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32861884"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0590"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A systematic review of COVID-19 and myocarditis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "P&#46;T&#46; Kariyanna"
                            1 => "B&#46; Sutarjono"
                            2 => "E&#46; Grewal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med Case Rep"
                        "fecha" => "2020"
                        "volumen" => "8"
                        "paginaInicial" => "299"
                        "paginaFinal" => "305"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32747875"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bib0595"
              "etiqueta" => "53"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46; Esposito"
                            1 => "A&#46; Palmisano"
                            2 => "L&#46; Natale"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcmg.2020.06.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "JACC Cardiovasc Imaging"
                        "fecha" => "2020"
                        "volumen" => "13"
                        "paginaInicial" => "2462"
                        "paginaFinal" => "2465"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32654966"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bib0600"
              "etiqueta" => "54"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "F&#46;P&#46; Polack"
                            1 => "S&#46;J&#46; Thomas"
                            2 => "N&#46; Kitchin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2020"
                        "volumen" => "383"
                        "paginaInicial" => "2603"
                        "paginaFinal" => "2615"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bib0605"
              "etiqueta" => "55"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "L&#46;R&#46; Baden"
                            1 => "H&#46;M&#46; El Sahly"
                            2 => "B&#46; Essink"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa2035389"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2021"
                        "volumen" => "384"
                        "paginaInicial" => "403"
                        "paginaFinal" => "416"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33378609"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bib0610"
              "etiqueta" => "56"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19 vaccine safety in adolescents aged 12&#8211;17 years &#8211; United States&#44; December 14&#44; 2020&#8211;July 16&#44; 2021"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46;M&#46; Hause"
                            1 => "J&#46; Gee"
                            2 => "J&#46; Baggs"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm7031e1"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2021"
                        "volumen" => "70"
                        "paginaInicial" => "1053"
                        "paginaFinal" => "1058"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34351881"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bib0615"
              "etiqueta" => "57"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vaccinating adolescents against SARS-CoV-2 in England&#58; a risk&#8211;benefit analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "D&#46; Gurdasani"
                            1 => "S&#46; Bhatt"
                            2 => "A&#46; Costello"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/01410768211052589"
                      "Revista" => array:6 [
                        "tituloSerie" => "J R Soc Med"
                        "fecha" => "2021"
                        "volumen" => "114"
                        "paginaInicial" => "513"
                        "paginaFinal" => "524"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34723680"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bib0620"
              "etiqueta" => "58"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Covid-19&#58; Sweden&#44; Norway&#44; and Finland suspend use of Moderna vaccine in young people &#8220;as a precaution&#8221;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46; Paterlini"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.n2477"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2021"
                        "volumen" => "375"
                        "paginaInicial" => "n2477"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34635488"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bib0625"
              "etiqueta" => "59"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COVID-19 vaccine safety in children aged 5&#8211;11 years &#8211; United States&#44; November 3&#8211;December 19&#44; 2021"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46;M&#46; Hause"
                            1 => "J&#46; Baggs"
                            2 => "P&#46; Marquez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.15585/mmwr.mm705152a1"
                      "Revista" => array:6 [
                        "tituloSerie" => "MMWR Morb Mortal Wkly Rep"
                        "fecha" => "2021"
                        "volumen" => "70"
                        "paginaInicial" => "1755"
                        "paginaFinal" => "1760"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34968370"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bib0630"
              "etiqueta" => "60"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protection against Covid-19 by BNT162b2 booster across age groups"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "Y&#46;M&#46; Bar-On"
                            1 => "Y&#46; Goldberg"
                            2 => "M&#46; Mandel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa2115926"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2021"
                        "volumen" => "385"
                        "paginaInicial" => "2421"
                        "paginaFinal" => "2430"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34879188"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bib0635"
              "etiqueta" => "61"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "L&#46;M&#46; Herzog"
                            1 => "O&#46;F&#46; Norheim"
                            2 => "E&#46;J&#46; Emanuel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.m4853"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2021"
                        "volumen" => "372"
                        "paginaInicial" => "m4853"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33402340"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bib0640"
              "etiqueta" => "62"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Emergence of new SARS-CoV-2 variant of concern omicron &#40;B&#46;1&#46;1&#46;529&#41; &#8211; highlights Africa&#39;s research capabilities&#44; but exposes major knowledge gaps&#44; inequities of vaccine distribution&#44; inadequacies in global COVID-19 response and control efforts"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "E&#46; Petersen"
                            1 => "F&#46; Ntoumi"
                            2 => "D&#46;S&#46; Hui"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijid.2021.11.040"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Infect Dis"
                        "fecha" => "2022"
                        "volumen" => "114"
                        "paginaInicial" => "268"
                        "paginaFinal" => "272"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34863925"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bib0645"
              "etiqueta" => "63"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omicron threat remains fuzzy as cases explode"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "K&#46; Kupferschmidt"
                            1 => "G&#46; Vogel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1126/science.acz9928"
                      "Revista" => array:6 [
                        "tituloSerie" => "Science"
                        "fecha" => "2022"
                        "volumen" => "375"
                        "paginaInicial" => "9"
                        "paginaFinal" => "10"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34990256"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bib0650"
              "etiqueta" => "64"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Heterologous prime-boost COVID-19 vaccination&#58; initial reactogenicity data"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "R&#46;H&#46; Shaw"
                            1 => "A&#46; Stuart"
                            2 => "M&#46; Greenland"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(21)01158-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2021"
                        "volumen" => "397"
                        "paginaInicial" => "2043"
                        "paginaFinal" => "2046"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34022146"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bib0655"
              "etiqueta" => "65"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19&#47;mRNA vaccination"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "T&#46; Schmidt"
                            1 => "V&#46; Klemis"
                            2 => "D&#46; Schub"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/s41591-021-01464-w"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Med"
                        "fecha" => "2021"
                        "volumen" => "27"
                        "paginaInicial" => "1530"
                        "paginaFinal" => "1535"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34312554"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bib0660"
              "etiqueta" => "66"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immunogenicity&#44; safety&#44; and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA&#44; viral-vector&#44; and protein-adjuvant vaccines in the UK &#40;Com-COV2&#41;&#58; a single-blind&#44; randomised&#44; phase 2&#44; non-inferiority trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "A&#46;S&#46;V&#46; Stuart"
                            1 => "R&#46;H&#46; Shaw"
                            2 => "X&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(21)02718-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2022"
                        "volumen" => "399"
                        "paginaInicial" => "36"
                        "paginaFinal" => "49"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34883053"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/08702551/0000004200000002/v1_202302081302/S0870255123000173/v1_202302081302/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "93365"
    "tipo" => "SECCION"
    "pt" => array:2 [
      "titulo" => "State of the Art"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "pt"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08702551/0000004200000002/v1_202302081302/S0870255123000173/v1_202302081302/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255123000173?idApp=UINPBA00004E"
]

Informação do artigo

ISSN: 08702551
Idioma original: Inglês

DOI:10.1016/j.repc.2023.01.003

Dados atualizados diariamente

Ano/Mês	Html	Pdf	Total

2024 Novembro	11	9	20
2024 Outubro	59	43	102
2024 Setembro	87	49	136
2024 Agosto	66	58	124
2024 Julho	87	59	146
2024 Junho	76	32	108
2024 Maio	108	21	129
2024 Abril	56	28	84
2024 Mar�o	61	26	87
2024 Fevereiro	56	31	87
2024 Janeiro	101	40	141
2023 Dezembro	54	22	76
2023 Novembro	42	35	77
2023 Outubro	30	18	48
2023 Setembro	24	21	45
2023 Agosto	24	29	53
2023 Julho	35	5	40
2023 Junho	30	9	39
2023 Maio	32	31	63
2023 Abril	39	20	59
2023 Mar�o	51	35	86
2023 Fevereiro	191	104	295
2023 Janeiro	26	41	67

Mostrar tudo

Indexada em:

Siga-nos:

Estatísticas

Indexada em:

Siga-nos:

Estatísticas

Receba a nossa Newsletter